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The association of clinical depres-
sion and anxiety with increased 
mortality and morbidity is well 
documented, but less is known about 
the effects of general psychological 
distress. The results of this study 
support a direct, independent as-
sociation of psychological distress 
with development of the metabolic 
syndrome and premature mortality. 
In addition, psychological distress is 
associated with inflammation among 
both genders and significantly el-
evated cardiovascular risk scores 
among men.
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ABSTRACT:   
 
The 12-item General Health Questionnaire (GHQ-12) is one of the most studied indicators 
of psychological distress.  
   The relationship between various psychological factors and cardiovascular disease (CVD) 
is well documented, but whether there is a significant association in both men and women, 
is currently unknown. Because atherosclerosis is nowadays seen as an inflammatory 
process, also the role of C-reactive protein (CRP) in this association is currently studied 
vigorously. Psychological factors have been associated also with the metabolic syndrome 
and all-cause mortality, but there are no prospective studies examining the relationship 
between GHQ-12 and the risk of developing MetS. Furthermore, the association between 
GHQ-12 and mortality has been studied only in British population.  
   This study was done to evaluate the association of general psychological distress, 
measured by the GHQ-12, with cardiovascular risk, C-reactive protein, metabolic syndrome 
and all-cause mortality in a community-based population sample in Pieksämäki, Finland.  
   The study showed a gender-specific association between psychological distress and 
cardiovascular risk: men with high psychological distress had 28-44% higher cardiovascular 
risk scores compared to men with low distress. Among women, no significant association 
was observed.    In addition, subjects with high psychological distress had a 1.79-fold risk 
for elevated CRP level representing high relative cardiovascular risk, compared to subjects 
with no distress, although age, gender, body-mass index and health behaviours were 
accounted for. 
   High psychological distress was also associated with a two-fold relative risk for the 
development of metabolic syndrome during a 7-year follow-up, even after adjusting for 
age, gender, socio-economic status and health behaviours, as well as with a 2.4-fold all-
cause mortality risk during an 11-year observation time, mainly due the excess mortality 
among distressed men.  
   In conclusion, these results support a direct, independent association of psychological 
distress with metabolic syndrome and premature mortality. In addition, psychological 
distress is associated with inflammation among both genders and significantly elevated 
cardiovascular risk scores among men. 
 
National Library of Medical Classification: QU 55, WG 120, WM 172.4 
Medical Subject Headings: Anxiety; C-Reactive Protein; Cardiovascular Diseases; Cross-Sectional Studies; 
Depression; Metabolic Syndrome X; Mortality; Prospective Studies; Questionnaires; Risk Assessment; Risk 
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TIIVISTELMÄ:   
 
General Health Questionnaire (GHQ-12) on yksi tutkituimmista psyykkisen 
kuormittuneisuuden mittareista. Sen 12 kysymystä kartoittavat vastaajan masennus-, 
stressi- ja ahdistuneisuusoireita, uniongelmia sekä yleistä onnellisuuden tunnetta.  
   Eri psyykkisten tekijöiden yhteyttä sydän- ja verisuonitauteihin on tutkittu paljon, mutta 
toistaiseksi on epäselvää, päteekö tämä yhteys sekä miehillä että naisilla. Koska 
ateroskleroosia pidetään nykytiedon valossa tulehduksellisena tilana, myös inflammaatiota 
mittaavan c-reaktiivisen proteiinin (CRP) rooli tämän ilmiön taustalla on kiivaan 
tutkimuksen kohteena. Psyykkiset tekijät on yhdistetty myös metabolisen oireyhtymän 
syntyyn ja kokonaiskuolleisuuteen, mutta GHQ-12 –mittarin yhteyttä metaboliseen 
oireyhtymään ei ole toistaiseksi tutkittu pitkittäistutkimuksissa. GHQ-12:n ja kuolleisuuden 
yhteyttä on puolestaan selvitetty vain brittiläisessä väestössä. 
   Tämän tutkimuksen tarkoituksena on arvioida psyykkisen kuormittuneisuuden (GHQ-
12) yhteyttä sydän- ja verisuonitautiriskiin, c-reaktiiviseen proteiiniin, metabolisen 
oireyhtymän syntyriskiin sekä kokonaiskuolleisuuteen. Kyseessä on väestötutkimus, joka 
suoritettiin Pieksämäellä vuosina 1997–1998. Seurantatutkimus tehtiin vuosina 2004–2005.  
   Tutkimustulosten mukaan psyykkisen kuormittuneisuuden ja sydän- ja 
verisuonitautiriskin välinen yhteys on sukupuolisidonnainen: psyykkisesti kuormittuneilla 
miehillä todettiin 28–44% korkeammat sydän- ja verisuonitautien riskipisteet verrattuna 
vähemmän kuormittuneisiin miehiin. Naisilla vastaavaa yhteyttä ei todettu. Lisäksi 
psyykkisesti kuormittuneilla oli 1.79-kertainen riski kohonneisiin CRP-arvoihin, jotka 
aiemmissa tutkimuksissa on yhdistetty kohonneeseen sydän- ja verisuonitautiriskiin, 
vaikka analyysit vakioitiin iällä, sukupuolella, pituus-painoindeksillä ja 
terveyskäyttäytymisellä. 
   Lisääntynyt psyykkinen kuormittuneisuus oli yhteydessä myös kaksinkertaiseen 
metabolisen oireyhtymän syntyriskiin 7 vuoden seuranta-aikana, vaikka iän, sukupuolen, 
sosio-ekonomisen aseman ja terveyskäyttäytymisen vaikutus vakioitiin. Samoin 
psyykkinen kuormittuneisuus oli yhteydessä 2.4-kertaiseen kokonaiskuolleisuuteen 11-
vuotisen seuranta-ajan kuluessa – pääasiassa miesten lisääntyneestä kuolleisuudesta 
johtuen.  
   Yhteenvetona voidaan todeta tämän tutkimuksen tulosten tukevan suoraa, itsenäistä 
yhteyttä psyykkisen kuormittuneisuuden, metabolisen oireyhtymän ilmaantumisen ja 
lisääntyneen kuolleisuuden välillä. Lisäksi psyykkinen kuormittuneisuus on yhteydessä 
inflammaatioon sekä naisilla että miehillä, mutta kohonneisiin sydän- ja verisuonitautien 
riskipisteisiin vain miehillä. 
 
Yleinen Suomalainen asiasanasto: c-reaktiivinen proteiini; kuolleisuus; metabolinen oireyhtymä – riskitekijät; 
psyykkinen kuormittavuus – riskit; sydän- ja verisuonitaudit – riskitekijät 
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1 Introduction  
Psychological distress is a term used to describe the general psychopathology of an 
individual - a combination of depressive symptoms, anxiety and perceived stress. The 12-
item General Health Questionnaire (GHQ-12) (1,2), introduced by David Goldberg in 1972, 
is one of the most widely used and studied indicators of psychological distress. The 
prevalence of high psychological distress measured by the GHQ-12 vary from 15% to 36% 
across different studies, countries and by the cut-off points used.  
     The relationship between various psychological factors and cardiovascular disease 
(CVD) has been investigated extensively in the last decades (3), since the traditional risk 
factors (age, gender, high blood pressure, smoking, dyslipidemia and diabetes) have been 
estimated to account only for approximately 50% of the variability in the risk for 
developing CVD (4,5). Previous studies have shown the association of cardiovascular 
mortality with psychological distress measured by GHQ-12 (6,7), but whether there is a 
significant association in both men and women, is currently unknown.  
     Over the last 20 years, appreciation of the role of inflammation in atherosclerosis has 
grown, and atherosclerosis is now seen as an inflammatory process (8,9). C-reactive 
protein (CRP) is an acute phase protein that is part of the systemic response to 
inflammation (10). Plasma levels of CRP <1mg/l, 1 to 3 mg/l and >3 mg/l has been 
proposed as representing low, average or high relative cardiovascular risk, respectively,  
when added to traditional risk factors (11). Only one previous study has studied the 
association of psychological distress measured by GHQ-12 with mean CRP levels (7), but 
the clinical relevance these results is hard to interpret, because the recommended 
cardiovascular risk cut-points for CRP were not used.  
     The metabolic syndrome (MetS) is a prevalent cluster of factors that increases the risk of 
cardiovascular diseases, type 2 diabetes mellitus and all-cause mortality (12,13). There is 
increasing interest in the association between psychological factors and MetS, and whether 
causal relationships are involved (14). Yet, there are no prospective studies examining the 
relationship between GHQ-12 and the risk of developing MetS. Inflammation is a recently 
purported physiological mechanism linking psychological distress to the development of 
MetS (15). However, the possible mediating role of CRP in the association between 
psychological factors and the risk of developing MetS has so far not been studied in a 
prospective setting.  
     Higher risk of premature all-cause mortality has been observed across a wide variety of 
mental disorders (16). There are only four previous prospective studies which have 
studied the association of psychological distress measured by the GHQ-12 with all-cause 
mortality, all of them in British population (6,7,17,18). CRP has also been shown to be 
related to all-cause mortality (19-21). However, there is very limited data on the possible 
gender-specifity between psychological distress and mortality.  
     In this study, the association of psychological distress (measured by GHQ-12) with 
cardiovascular risk scores, development of MetS and all-cause mortality was examined. 
Also the role of CRP in these associations was studied. The study population in this 
community-based study consisted of five age groups born in 1942, 1947, 1952 and 1962 in 
the town of Pieksämäki, in eastern Finland. 
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2 Review of literature  
2.1 PSYCHOLOGICAL DISTRESS 
2.1.1 Definitions of psychological distress 
There is no universally accepted definition for psychological distress. McGraw-Hill 
Concise Dictionary of Modern Medicine (2002) defines psychological distress as “the end 
result of factors– e.g., psychogenic pain, internal conflicts, and external stress that prevent 
a person from self-actualization and connecting with 'significant others'” (22).  
     In order to understand the complex nature of psychological distress, various different 
theoretical perspectives have been used.  Psychodynamic theory emphasises the role of 
unconscious processes and defence mechanisms. Psychological distress is seen as an 
unconscious conflict – as an attempt to cope with present difficulties using past childhood 
defence mechanisms.  Behavioral theory, on the other hand, focuses on ways in which 
individuals learn to associate stress responses with certain situations. According to 
cognitive theory, negatively biased cognition is the core process of psychological distress. 
Distressed individuals have typically a negative view of themselves, their environment 
and the future, which could be the result of inappropriate ways of interpreting their past 
experiences. (23) Interpersonal theories attribute psychological distress to dysfunctional 
patterns of interaction (24). Psychological distress is described as maladaptive behaviour 
observed in interpersonal relationships, which is caused by past or present unsatisfactory 
relationships.  
     Psychological distress has also been defined as a combination of depressive symptoms, 
anxiety and perceived stress (2). This definition of psychological distress also widens the 
range of psychopathology from clinically diagnosed diseases (e.g. depression or anxiety 
disorders) to symptoms falling below the diagnostic threshold for a given disorder (25). 
This is relevant for number of reasons. First, subthreshold psychological disorders are 
common. In a study of 554 primary care patients by Rucci et al. (2003) (26), the prevalence 
of subthreshold depressive and anxiety disorders was 9.9% and 8.3%, respectively – both 
exceeding the prevalences of corresponding clinical disorders (4.6% and 7.6%, 
respectively). Olfson et al. (1996) (27) reported that subthreshold symptoms were more 
common than their respective clinical diagnoses in a sample of 1001 adult primary care 
patients: panic (10.5% vs. 4.8%), depression (9.1% vs. 7.3%), anxiety (6.6% vs. 3.7%) and 
obsessive-compulsive (5.8% vs. 1.4%).  
     Second, even subthreshold level symptoms are associated with reduced quality of life 
and functional impairment. Collings et al. (2005) (28) found that in a sample of 775 
primary care patients there was no significant difference in the level of disability between 
patients with subthreshold disorders and patients with clinical disorders. In a large WHO 
Collaborative Study on psychological problems in general health care, covering 14 
countries, most major cultures and languages and over 25 000 patients, a dose-response 
relationship was found between severity of mental illness and disability (29). Also Berardi 
et al. (1999) (30) reported similar results in their sample of 323 primary care attenders: the 
prevalence of clinical disorders and subthreshold disorders was 12.4% and 18% 
respectively and significant impairment in physical and mental functioning was seen in 
both categories. 
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     Third, there is an elevated risk for individuals with subthreshold disordes for 
developing full-syndromal psychiatric disorder (31). In a study by Lewinsohn et al. (2000) 
(32) with 3003 subjects from all age groups from adolescents to elderly, increasing levels of 
depressive symptoms were associated with elevated incidence of major depression and  
increasing levels of psychosocial dysfunction. 
     These findings suggest that depression and other psychological disorders may best be 
conceptualized as a continuum and especially in community and primary care settings the 
criteria for defining also subthreshold psychological disorders may aid early detection and 
timely intervention for people at risk (33). Because psychological distress can be defined as 
a combination of depressive symptoms, anxiety and perceived stress and therefore is 
continuous rather than categorized in nature, it can be a useful concept in early detection 
and timely intervention.   
2.1.2 The 12-item General Health Questionnaire (GHQ-12) 
Psychiatric researchers have developed and used a bewildering variety of assessment tools 
to detect psychopathology among patients and in the community level. The Symptom 
Checklist 90 (SCL-90) (34), Hamilton Rating Scale for Depression (HRSD) (35,36), 
Montgomery-Åsberg Depression Rating Scale (MADRS) (37), Kessler Psychological 
Distress Scale (K10 and K6) (38), Beck Depression Inventory (BDI) (39), the Revised 
Clinical Interview Scale (CIS-R) (40) and the Everyday Feeling Questionnaire (EFQ) (41) 
are among the best validated assessment instruments.  
     The General Health Questionnaire (GHQ) (1,2), introduced by David Goldberg in 1972, 
is one of the most widely used and studied indicators of psychological distress. In some 
studies, the GHQ has been refered as “the current de facto standard of mental health 
screening” (42). The original GHQ had 60, 36, 30 or 12 items (GHQ-60, GHQ-36, GHQ-30 
and GHQ-12), but already in 1979 Goldberg and Hillier introduced a scaled version of the 
GHQ, based on 28 items derived from a factor analysis of the 60-items scale (GHQ-28) (43). 
GHQ-28 contained four subscales: somatic symptoms, anxiety and insomnia, social 
dysfunction and severe depression. The shortest version (GHQ-12) is contained within in 
30, 36 and 60-item questionnaire, but it contains no questions about somatic symptoms (2). 
It has gained acceptance, because of its space-saving properties in survey studies. GHQ-12 
is comprised of twelve questions regarding general level of happiness, experience of 
depressive and anxiety symptoms, perceived stress and sleep disturbance over the last 
four weeks (Table 1). Six of the questions are positively phrased (questions 1,3,4,7,8 and 
12) and six negatively phrased. Each question has a four-point response scale: for 
positively phrased questions e.g. feeling reasonable happy (better than usual, same as 
usual, worse than usual, much worse than usual) and for negatively phrased questions e.g. 
feeling unhappy and depressed (not at all, no more than usual, more than usual, much 
more than usual). 
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Table 1. The 12-item General Health Questionnaire items 
 
Have you recently: 
 
1. Been able to concentrate on whatever you are doing? 
2. Lost much sleep over worry? 
3. Felt that you are playing a useful part in things? 
4. Felt capable of making decisions about things? 
5. Felt constantly under strain? 
6. Felt you could not overcome your difficulties? 
7. Been able to enjoy your normal day-to-day activities? 
8. Been able to face up to your problems? 
9. Been feeling unhappy and depressed? 
10. Been losing confidence in yourself? 
11. Been thinking yourself as a worthless person? 
12. Been feeling reasonably happy all things concerned? 
 
 
The original rating method of the four-point response scale is referred as the GHQ (or 
binary) method (0-0-1-1; e.g. for negatively phrased questions: not at all = 0, no more than 
usual = 0, more than usual = 1, much more than usual = 1) (2) and the points are summed 
to a global score ranging from 0-12. Another way of rating the questionnaire is the so-
called modified Likert scoring method, in which the overall score is calculated by 
assigning separate scores (0-3) to each response and summing across the items (44). 
Goodshild and Duncan-Jones (1985) (45) proposed yet another scoring method (C-GHQ 
method), where the positively phrased items are coded 0-0-1-1 and the negatively phrased 
0-1-1-1. They argue that the response “no more than usual”, to a negatively phrased item 
describing pathology, should be treated as an indicator of chronic illness rather that of 
good health.  Although all the scoring methods have been used in the past, most research 
using the GHQ-12 during the last decade has relied on the GHQ method. 
     There are many validating studies of the GHQ-12 in different countries, cultures and 
languages (46). In the WHO study of mental illness in general health care, Goldberg et al. 
(1997) (46) have validated the GHQ-12 against standardized psychiatric interviews for 
5438 patients across 15 centers around the world. The results were uniformly good, with 
the average area under the ROC curve 0.88, range from 0.83 to 0.95. Additionally, complex 
scoring methods (C-GHQ and Likert methods) offered no advantages over the simpler 
GHQ method. In the Finnish validation study by Holi et al. (2003) (47) with 207 psychiatric 
outpatients and a community sample of 315 subjects, the internal consistency of the GHQ-
12 was good (Crohnbach’s α = 0.94). The external validation criterion was belonging to 
either functional (community) sample or moderately disturbed (psychiatric outpatient) 
sample. Under these assumptions, the validity of GHQ-12 was also good (area under the 
ROC curve 0.86). 
      There may be significant variations in the best threshold values of the GHQ-12 in 
detecting psychiatric morbidity in different countries and cultures. In the above 
mentioned WHO study by Goldberg et al. (1997) (46), the optimal thresholds varied across 
the 15 study centers: 1/2 (8 centers), 2/3 (5 centers), 3/4 (one center) and 6/7 (one center. In 
the study validating the GHQ-12 in the Finnish population (47), the optimal cut-off point 
was 3/4 by using the optimal trade-off between sensitivity and specificity (Youden’s 
index). 
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     In most studies, the GHQ-12 has been treated as a unidimensional measure. There are 
factor analysis studies, however, which challenge this view. In 1991, Graetz (48) 
introduced a three factor model arguing that GHQ-12 measures psychiatric dysfunction in 
three domains (social dysfunction, anxiety and loss of confidence). The three factor model 
has gained support also in other studies (49-57), while other studies have identified only 
two factors, most commonly named depression and social dysfunction (55,58-62).  
     However, none of the complete factor models that have been proposed have been 
consistently replicated across studies (63). Furthermore, using the proposed factors 
separately does not seem to offer many practical advantages in differentiating clinical 
groups or identifying association with clinical or health-related quality of life variables 
(50). It has also been argued that the division of the GHQ-12 into positively phrased and 
negatively phrased statements could introduce response bias which should be taken into 
account when deriving factors (64). When this possible bias was taken into account, 
superiority of the unidimensional model has been reported (65).  
2.1.3 Overlapping of GHQ-12 with other psychiatric assessment tools 
There has been some debate about the conceptual overlap between psychological distress 
and other, clinically distinct psychiatric disorders, e.g. depression and anxiety. Thus, the 
rationale of screening general psychological distress with GHQ-12 in stead of measuring, 
for instance, the level of depression with distinct assessment tool can be questioned. 
However, the results of some factor analyses studies suggest, that comorbidity between 
different psychiatric disorders results from common, underlying core psychopathological 
processes (66,67) and the authors of these studies suggest that the research should be 
focused on these core processes themselves, rather than on their varied manifestations as 
separate disorders.  
     Hotopf et al. (1998) (68) studied the relationship between four psychiatric assessment 
tools within a mixed primary care population. The assessment tools in the study included 
Hamilton Rating Scale for Depression (HRSD), Beck Depression Inventory (BDI), the 
Revised Clinical Interview Scale (CIS-R) and the 12-item General Health Questionnaire. 
Despite of the similarities, the different screening instruments are not identical. First, the 
instruments were originally designed for different uses: the GHQ-12 is a screening 
instrument for psychiatric disorders in the community, whereas the BDI and HRSD are 
supposed to be used in patients with previously diagnosed depression and to monitor the 
severity of depression. The CIS-R is meant to be used as a diagnostic interview capable of 
detecting ten diagnoses, but it also produces a global score of severity. Second, GHQ-12 
and BDI are self-administered questionnaires, the HRSD is based on an unstructured 
clinical interview and the CIS-R is a structured interview. Third, although there is 
considerable conceptual overlap between the instruments (from 32 different symptoms 
that contribute to the global score of the BDI, HRSD and CIS-R, only 9 are unique to any 
other scale (68)), the GHQ-12 also measures anxiety and perceived stress in addition to 
depressive symptoms.   
     According to Hotopf et al. (1998) (68), the total score for each of the four scales 
correlated closely with every other one (correlation coefficients = 0.70 – 0.79). Lipsanen et 
al. (2004) (69) reported similar, high correlations between GHQ-12, BDI and the 
somatization part of the Symptom Check List 90 (SCL-90) (correlaton coefficients = 0.68 
and 0.46, respectively). They concluded that while psychological distress, depression and 
somatization are distinct constructs, they correlate to a considerable extend.  
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2.1.4 Prevalence of psychological distress measured by the GHQ-12 
The reported prevalence figures for high psychological distress measured by the GHQ-12 
vary from 15% to 36% across different studies, countries and by the cut-off points used. In 
a population-based sample of 4501 adults in North-West of England, 28% of the subjects 
scored 4-12 points indicating high psychological distress (6). Harrison et al. (1998) (70) 
reported similar prevalence (27% for high psychological distress) in an English study of 
38000 responders. In the Scottish Health Survey with 6576 healthy men and women, 959 
subjects (15%) were categorized as high distressed (7). In a Nigerian sample of 272 primary 
care patients, 21% was categorized as psychologically distressed (71). Furthermore, in 
study of 4867 primary health care patients in Australia, 36% had scores on GHQ-12 
indicating psychological distress (72). 
     There are also some Finnish studies on the prevalence of high psychological distress 
measured by the GHQ-12. Virtanen et al. (2007) (73) used the recommended cut-off point 
of 3/4 in defining subjects with high psychological distress. In their study of 48592 subjects 
from the Finnish Public Sector Study, the prevalence of high psychological distress was 
25%. Laaksonen et al. (2009) (74) defined high psychological distress as scoring 3 or more 
in GHQ-12 in their study of white-collar employees in Helsinki, and reported 27% of 
women and 23% of men as being psychologically distressed. In the Health 2000 Study in 
Finland with a representative population sample of  8028 subjects, the mean GHQ-12 score 
for men was 1.68 and for women 1.95 (75).  
     The GHQ-12 is associated with various sociodemographic, clinical and behavioural 
variables. These associations are summed in Table 2 and they are discussed in more detail 
in the next four chapters (2.1.5, 2.1.6, 2.1.7 and 2.2).  
 
Table 2. Associations between GHQ-12 and sociodemographic, clinical and behavioural 
variables according to literature review. 
 
 
High psychological distress (GHQ-12) 
 
Strong support 
for positive 
association 
Some support 
for positive 
association 
No clear 
association 
Some support 
for negative 
association 
Strong support 
for negative 
association 
Female gender +     
Higher age   +    
High education    +  
Living alone +     
Obesity  +    
 
High C-reactive 
protein levels  
 
+ 
 
 
 
Smoking +     
 
Regular physical 
activity  
  
 
 
+ 
 
Regular alcohol 
consumption  
 
+ 
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2.1.5 Sociodemographic variables and psychological distress 
It has been long known that women generally report higher levels of depression, 
psychiatric disorders and distress compared to men (76,77). Similar association has been 
observed also in the studies using the GHQ-12. In the North West Regional Health Needs 
Survey with 38 000 responders, 29% of women scored above the GHQ threshold of 3, 
compared to 23% of men (70). In the Scottish Health Survey of 6576 healthy men and 
women, risk for high psychological distress (GHQ-12 points 4 or more) was higher among 
women compared to men (OR 1.61 after adjusting with age, health behaviours and 
obesity) (7). In the British Whitehall II study (n=3116) and in the Finnish Helsinki Health 
Study (n=6028), the age-adjusted prevalence of high psychological distress (GHQ-12 points 
3 or more) was higher among women in both studies (26% vs. 23% in Helsinki, 29% vs. 
23% in London) (78). In another Finnish study (The Health 2000 Study) by Pirkola et al. 
(2009) (75) with a nationally representative sample of 8028 subjects, the mean GHQ-12 
score for men was 1.68 and for women 1.95. Thus, there seems to be a clear gender 
difference in psychological distress, which possibly can not be explained with other 
confounding factors: Weich et al. (2001) (79) reported in their longitudinal study of 9947 
subjects using the data from the British Household Panel Survey that this gender 
difference in psychological distress was not explained by type of social roles occupied nor 
socio-economic status. 
     The relationship between age and psychological distress measured by the GHQ-12 is 
controversial. In the population-based study by Hamer et al. (2009) (80) with 15158 
subjects,  age was not statistically related to psychological distress. Robinson et al. (2004) 
(6) reported similar, nonsignificant, results in a population-based study in North West 
England. However, in the Finnish Health 2000 Study, the age of 65 or more was 
significantly associated with high psychological distress after adjusting with gender and 
physical health (75). 
     Faris and Dunham (81) demonstrated already in 1939 an inverse relationship between 
socio-economic status and mental disorders. In their review of five large scale population-
based studies in 2003, Fryers et al. (82) found a positive association between less education 
and high psychological distress in four out of five studies. Since then, population based 
studies using the GHQ-12 have yielded mixed results. In the study of 5703 women in rural 
India, higher education was less often associated with high psychological distress (GHQ-
12 points 5 or more) compared to low education (OR 0.6) (83). Belek (2000) (84) reported 
similar, significant association in his study of 1092 adults in Turkey. However, in the study 
of 6028 Finnish and 3116 English public sector employees, no association was found 
between education level and high psychological distress measured by GHQ-12 points of 3 
or more (78). Thus, the relationship between education and psychological distress is yet to 
be fully elucidated.  
     Marital status has been associated with psychological distress measured by the GHQ-12 
in previously published studies. Using the population-based data from the Scottish Health 
Survey with 13158 study subjects,  Hamer et al. (2009) (80) reported that psychologically 
distressed subjects (GHQ-12 points 4 or more) were significantly less often married than 
non-distressed subjects (51% vs. 65%). Similar statistically significant association was also 
reported in a Chinese study with 14632 subjects (85). In a Finnish study among 3949 white-
collar workers, living with spouse/partner decreased significantly the odds for high 
psychological distress for women (OR 0.77), among men there was no significant 
association (74).  
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2.1.6 Health behaviors and psychological distress 
It is generally known that adverse health behaviors may arise as a coping response to 
psychological distress. Adler and Mathews (1994) (86) conducted an extensive review of 
literature in this field in 1994. They concluded that psychological distress is indeed 
associated with health-damaging behaviors, such as smoking, sedentary lifestyle and 
excessive use of alcohol. Since then numerous studies have focused on these associations.  
     High levels of psychological distress are associated with higher levels of smoking (87-
90), although some studies suggest that among different ethnic groups, this association is 
relatively specific to white individuals (91). This association between psychological 
distress and smoking has been observed also among studies using GHQ-12. In their 
population-based study of 4501 subjects, Robinson et al. (2004) (6) found that subjects with 
high psychological distress (GHQ-12 points 4 or more) were much more likely to smoke 
compared to subjects with no psychological distress (20% vs. 6%). Hamer et al. (2008) (7) 
reported similar, although higher prevalences from the Scottish Health Survey (43% vs. 
27%). Among Finnish white-collar employees, current smokers were more likely to have 
GHQ-12 points 3 or more indicating psychological distress (OR for women: 1.29, OR for 
men: 1.70) (74). 
     In the U.S. National Comorbidity Survey with 8093 adult subjects, a negative 
association was found between regular physical activity and depressive and anxiety 
disorders (92). Also in the nationwide Norwegian survey with 12310 subject in the age of 
30-60 years, exercise was negatively associated with psychological distress (OR 0.76) (93). 
Ezoe et al. (1994) (94) found that after controlling for age, marital status and somatic 
conditions, physical exercise was significantly related to psychological distress measured 
by the GHQ-28 in the sample of 2800 male and female Japanese factory workers. Hamer et 
al. (2009) (95) used the GHQ-12 in the Scottish Health Survey with 19842 healthy men and 
women. Any form of daily physical activity was associated with a lower risk of 
psychological distress (based on a score of 4 or more on the GHQ-12) after adjustment for 
age, gender, social economic group, marital status, body mass index, long-standing illness, 
smoking and survey year (OR 0.59). A dose-response relationship was apparent, with 
moderate reductions in psychological distress with less frequent activity. Among Finnish 
white-collar employees (n=3949), physically inactive subjects were more likely to have 
GHQ-12 points 3 or more indicating psychological distress (OR for women: 1.21, OR for 
men: 1.81 ) (74).  
     The association between high psychological distress measured by the GHQ-12 and 
alcohol consumption is controversial. In a study among Royal Navy personnel with a 
sample of 2236 subject, high psychological distress (GHQ-12 score 4 or more) was a risk 
factor for heavy drinking (22-42 units of alcohol per week) but not for binge drinking 
(drinking 9 or more units in a drinking session) (96). Also Hamer et al. (2008) (7) reported 
that the mean alcohol consumption (units/week) among psychologically distressed 
subjects was significantly higher compared to non-distressed subjects (21 vs. 17 for men, 8 
vs. 6 for women). However, in a study among medical students in Chile, no association 
was observed between psychological distress and alcohol consumption (97). Also the two 
Finnish studies by Saarni et al. (2008) (98) and Laaksonen et al. (2008) (74), yielded no 
significant  association between alcohol consumption and psychological distress.  
2.1.7 Obesity and psychological distress 
There has been some support for the association between obesity and psychological 
distress. McElroy et al. (2004) (99) conducted an extensive review of the literature in 2004 
and concluded that there is an association between psychological distress and obesity, 
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particularly in women. Among men, the results were inconclusive. In the Scottish Health 
Survey with 6576 healthy men and women, 20.8% of non-distressed subjects (GHQ-12 
points 0-3) and 22.8% of distressed subjects (GHQ-12 ≥ 4) were reported obese (BMI > 30). 
(7). However, when adjusting with age, gender and health behaviours, this association 
was no longer significant. Among university employees in Rio de Janeiro, BMI showed a 
significant association with psychological distress in women, but not in men (100). After 
adjusting with income and self-reported health problems, also this association did not 
persist.  Other series of studies have explored the opposite causal direction—that is, 
obesity as a risk factor for future mental disorder. Again, the results from these studies 
have been contradictory (101). However, in a literature review by Atlantis et al. (2008) 
(102), a weak level of evidence was observed supporting the hypothesis that obesity 
increases the incidence of mental disorders.  
     Several mechanisms could explain these two causal directions. In societies in which 
obesity is stigmatized, this may lead to increased risk of psychological distress (103). On 
the other hand, psychological distress is associated with disordered eating, which could 
lead to obesity in the future (104). Kivimäki et al. (2009) (101) studied the direction of 
association between psychological distress measured by the GHQ-30 and obesity among 
4363 adults in prospective cohort study with four measurements over 19 years. They 
concluded that the direction of causality is from psychological distress to increased future 
risk of obesity. This association was also cumulative with repeated episodes of 
psychological distress.  
2.2 C-REACTIVE PROTEIN (CRP) AND PSYCHOLOGICAL DISTRESS 
C-reactive protein (CRP) is an acute phase protein that is part of the systemic response to 
inflammation (10). The major part of the CRP present in the plasma comes from the liver, 
where the synthesis of CRP is mainly regulated by interleukin-6, which in turn is up 
regulated by other inflammatory cytokines such as interleukin-1 (105). High-sensitivity 
CRP (hsCRP) has been shown to be related to all-cause mortality. In the MONICA/KORA 
Augsburg Cohort Study 1984-1998 with a study sample of 3620 middle-aged men, subjects 
with hsCRP >3 mg/l at baseline showed an almost 2-fold increased risk to die compared to 
those with hsCRP <1 mg/l (19). Similar results have also been reported in Finland (20). This 
association has been observed also among women and there seems to be a dose-response 
type of linear trend between higher hsCRP-levels and increasing mortality (21).  
     Clinical depression has been associated with elevated hsCRP levels in some population 
based cross-sectional studies (106-109), where as some studies reported null findings 
(110,111). Also in patients with cardiovascular disease results are mixed: positive (112), 
null (113) and even negative (114) associations have been reported. The relationship 
between sub-clinical depressive symptoms and elevated hsCRP concentration is also 
controversial. In a recently published population-based study with over 6000 subjects by 
Elovainio et al. (2009) (115), higher level of depressive symptoms (measured by the BDI) 
was related to higher CRP levels in both men and women. Other cross-sectional studies 
have reported similar results (116,117), while others report no association (118-120). 
Perceived stress has been associated with elevated hsCRP levels in some cross-sectional 
studies (119,121). 
     There is only one study which has studied the association of psychological distress 
measured by GHQ-12 with hsCRP. Hamer et al. (2009) (7) analysed data from the Scottish 
Health Survey in a cross-sectional study setting, and reported that the mean hsCRP level 
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among distressed subjects (GHQ-12 points ≥ 4) was significantly higher (4.73 mg/l) 
compared to non-distressed (GHQ-12 points 0-3) subjects (3.29 mg/l).  
     The direction of the association between psychological factors and hsCRP-levels is 
controversial and needs to be addressed in a prospective setting. Gimeno et al. (2009) (122) 
reported in the Whitehall II study of 3339 British white-collar civil servants that baseline 
hsCRP predicted depression at follow-up, while baseline symptoms of depression were 
not associated with hsCRP levels at follow-up. Nabi et al. (2008) (123) reported that 
psychological distress did not predict elevated hsCRP concentration at follow-up. In 
contrast, in a study by Fuligni et al. (2009) (124), greater frequency of daily interpersonal 
stress was associated with higher levels of hsCRP at follow-up among adolescents. Thus, 
the direction of causality is yet to be fully elucidated.  
2.2.1 Proposed mechanisms linking psychological distress and CRP 
Psychological factors and systemic inflammation can interact through many mechanisms. 
These include physiological as well as behavioral mediating pathways. In addition, 
demographic characteristics, such as gender and age, influence the association, although 
the exact mechanism is unknown.  
2.2.1.1 Role of gender and age 
As mentioned in 2.1.5, women generally report higher levels of psychiatric disorders and 
distress compared to men (70,76-78). Some studies also report a link between older age 
and higher psychological distress (75). In addition, it is known that age and gender 
influence the distribution of hsCRP values: older persons and women have higher hsCRP 
concentrations.  In a population-based sample of 229 subjects (50 to 67 years), female 
participants were found to have higher CRP concentrations even after adjusting with 
health behaviours and psychosocial variables (119). Wong et al. (2001) (125) reported 
similar findings in their study of 4472 men and 5212 women, aged 30–74 years. In the 
Third National Health and Nutrition Evaluation Survey with over 22,000 individuals age 
≥4 yrs representative of the non institutionalized population of the United States, the mean 
CRP concentration was positively associated with age (126). Based on these findings, age 
and gender should be considered as potential confounding factors when studying the 
relationship between psychological distress and CRP.  
2.2.1.2 Role of obesity 
As mentioned in 2.1.7, there has been some support for the association between obesity 
and psychological distress (99,102), and the direction of association seems to be from 
psychological distress to future obesity (101). Several studies have also associated 
increased hsCRP concentrations with high body mass index (BMI) values, reflecting the 
potential role for cytokines originating from adipose tissue (127). In the Third National 
Health and Nutrition Examination Survey with a representative population-based sample 
of 16616 adult men and women, the odds ratio for elevated CRP was 2.13 for obese men 
and 6.21 for obese women after adjustment for potential confounders, including smoking 
and health status (128). These results have been confirmed in several other studies 
(119,125,129,130). Greenfield et al. (2004) (131) studied the association between obesity and 
elevated CRP-levels in a sample of 194 monozygotic twins. They concluded that CRP was 
strongly related to total and central abdominal obesity independent of genetic influences. 
Hamer et al. (2008) (121) studied inflammation as an intermediate pathway in the 
association between psychosocial stress and obesity. They concluded that inflammatory 
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markers (CRP and fibrinogen) independently accounted for approximately 25% of the 
association between stress and obesity. 
2.2.1.3 Role of health behaviours 
As mentioned in 2.1.6, psychological distress has been associated with higher levels of 
smoking (6,74,87-90). Smoking has also been associated with increased CRP-levels in 
several studies (119,129,130). In the large scale population study of 4472 men and 5212 
women, aged 30–74 years, after adjusting for age, BMI, diabetes and systolic blood 
pressure, cigarette smoking was associated with a greater likelihood of having higher CRP 
levels in men. Interestingly, among women, nonsmoking status remained independently 
associated with the probability of elevated CRP levels (125). Among women, also positive 
associations between smoking and elevated CRP levels has been reported (132).  
     There is a negative association between psychological distress and increased physical 
exercise (74,92-95), see 2.1.6. Physical exercise, in turn, has been associated with decreased 
CRP levels. Mattusch et al. (2000) (133) studied 14 subjects preparing for a marathon and 
reported a significant decrease in the median CRP level. They conclude that intensive 
regular exercise has a systemic anti-inflammatory effect. In their review article “The anti-
inflammatory effect of exercise” , Petersen et al. (2005) (134) suggest that during exercise, 
interleukin 6 (IL-6) is produced by muscle fibers, which in turn down regulates the 
synthesis of CRP in the liver.  
     Although the relationship between high psychological distress measured by the GHQ-
12 and alcohol consumption is controversial (7,74,96-98), see 2.1.6, moderate alcohol 
consumption has been independently associated with decreased concentrations of CRP 
(131). In the Pravastatin Inflammation/CRP Evaluation Study among 1732 men and 1101 
women, moderate alcohol consumption was associated with lower CRP concentrations 
than no or occasional alcohol intake (135). The authors conclude that alcohol may 
attenuate cardiovascular mortality in part through an anti-inflammatory mechanism. 
Imhof et al. (2001) (136) reported a U-shaped association between alcohol consumption 
and mean values of CRP among men after adjustment for age, smoking, body-mass index, 
HDL and LDL cholesterol, history of hypertension, education, and income in their 
population-based study of 781 men and 995 women. Among women, similar but non 
significant association was observed. In a sample of 959 healthy male and 473 healthy 
female health professionals, both men and women who consumed 1-2 drinks/drinking day 
had significantly lower CRP levels (-10% in men, -32% in women) compared to non-
drinkers (137).  
2.2.1.4 Pathophysiological mechanisms 
Psychological factors and systemic inflammation also interact through complex 
pathophysiological mechanisms. First, inflammation may lead to depression. 
Proinflammatory cytokines (e.g., interleukin-1 and interleukin-6, which regulate the 
production of CRP) can access the brain, where they can alter metabolism of relevant 
neurotransmitters such as serotonin and dopamine and disrupt synaptic plasticity through 
alterations in relevant growth factors (138). Exposure to inflammatory mediators can 
produce sickness behaviour (e.g., anhedonia, anorexia and hyposomnia) that resemble 
depressive symptoms (139). Second, depression may lead to inflammation. Psychosocial 
stress activates the hypothalamic-pituitary-adrenocortical axis and sympathetic nervous 
system, which releases various stress hormones (i.e., catecholamines, corticosteroids, 
growth hormone and glucagons). These, together with cytokines induced by stress, initiate 
the acute phase response (10,138).   
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2.3 CARDIOVASCULAR DISEASE (CVD) AND PSYCHOLOGICAL 
DISTRESS 
Cardiovascular disease (CVD) is the leading cause of death worldwide, and global 
cardiovascular deaths are projected to increase from 16.7 million in 2002 to 23.3 million in 
2030 (140).  Although traditionally seen as a problem of the western societies, CVD is 
nowadays a truly global epidemic extending also into the developing world (141). 
2.3.1 Risk factors for developing CVD 
It is widely accepted that age, gender, high blood pressure, smoking, dyslipidemia and 
diabetes are the major risk factors for developing CVD (142-144). It is also recognized that 
CVD risk factors cluster and interact in many ways to promote vascular risk (145). This 
has led to the development of multivariable risk prediction algorithms combining 
traditional main risk factors, which can be used to assess in individual patients the total 
risk for development of CVD. 
     Framingham CVD risk prediction model (144) is one of the most widely used risk 
assessment tools. It was further developed from the previous model(142,142), which only 
assessed the risk for coronary heart disease (CHD) (146). The Framingham CVD risk 
model assesses the 10-year risk for any CVD events (fatal or non-fatal), by using gender, 
age, total cholesterol, HDL cholesterol, systolic blood pressure,  anti-hypertensive 
medication, smoking and diabetes as variables. The validation studies have reported good 
performance for this risk assessment tool (147,148). Another widely used instrument is the 
European SCORE model (143), which assess the 10-year risk for fatal cardiovascular event 
and uses gender, age, smoking, systolic blood pressure and total cholesterol as variables. 
The SCORE model has also been validated in several studies and has performed well 
(148,149). 
      However, it has been estimated that the traditional risk factors (age, gender, high blood 
pressure, smoking, dyslipidemia and diabetes) account only for approximately 50% of the 
variability in the risk for developing CVD (4,5). As a consequence, a wider perspective has 
been called for with additional assessment of both health behaviours (including dietary 
habits, physical activity and alcohol consumption) as well as psychosocial factors, when 
the CVD risk is assessed (150). Indeed, in the INTERHEART study with 15152 cases and 
14820 controls in 52 countries, dyslipidemia, smoking, hypertension, diabetes, abdominal 
obesity, psychosocial factors, consumption of fruits and vegetables, alcohol consumption, 
and physical activity accounted for up to 90% of the risk of myocardial infarction 
worldwide in both sexes and at all ages in all regions (151).  
     In addition to health behaviours and psychosocial factors, a legion of so-called novel 
risk factors for CVD have emerged. These include e.g., impaired fasting glucose, angle-
brachial index, carotid intima-media thickness, homocystein, fibrinogen, impaired 
fibrinolysis, increased platelet reactivity, hypercoagulability, lipoprotein(a), exposure to 
herpes simplex virus-1 and Chlamydia,  and inflammatory markers such as white blood 
cell count, C-reactive protein and interleukin-6 (5,152-156). The clinical usefulness of these 
novel risk factors is currently under discussion (157,158). 
2.3.2 Psychological distress and CVD 
The relationship between various psychological factors and cardiovascular disease has 
been investigated extensively in the last decades (3,159-161). In a review by Everson-Rose 
et al. (2005) (3), negative emotional states, chronic psychosocial stressors and social factors 
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were all significantly associated with increased risk of cardiovascular morbidity and 
mortality.  
     Several studies have shown the association of cardiovascular mortality with 
psychological distress measured by the GHQ-12 (6,7) and GHQ-30 (162-165). In the 
Whitehall II study with 7081 English civil service employees, baseline psychological 
distress measured by the GHQ-30 was associated with an increased incidence of overall 
self-reported CHD (OR for men 1.83, for women 1.60) after adjustment for age, 
employment grade and length of follow-up. Adjustment for health behaviours, marital 
status, social networks and work characteristics reduced the risks for incident CHD by 
12% in men and by 10% in women (162). Using the GHQ-12, in their population based 
study of 4501 adults, Robinson et al. (2004) (6) reported that individuals with high levels of 
psychological distress (GHQ-12 scores ≥ 4) experienced almost twice the risk of death for 
ischemic heart disease (HR 1.90) compared with non-distressed individuals (GHQ-12 score 
0). In the Scottish Health Survey with 6,576 healthy men and women, age and gender 
adjusted relative risk for CVD events for psychologically distressed subjects (GHQ-12 
scores ≥ 4) was 1.54 compare to non-distressed subjects (GHQ-12 points 0-3) (7).  
2.3.2.1 Gender-differences in association of psychological distress with CVD risk 
According to review by Everson-Rose et al. in 2005 (3), the association between 
psychological factors and cardiovascular diseases seems to be weaker and less studied 
among women. Since then, some new studies have been published in this field. Among 
5073 healthy Dutch women aged 46-54 years, Denollet et al. (2008) (166) reported that 
anxiety predicted premature cardiovascular death (HR 2.77) among women, after 
adjustment for standard risk factors and depression. As part of the INTERHEART study, 
which includes 11119 cases and 13648 controls from 52 countries, various ethnic groups 
and both genders, Rosengren et al. (2004) (167) investigated the association of psychosocial 
risk factors with risk of acute myocardial infarction (MI). All used factors (e.g. general 
stress, financial stress, locus of control and depression) were significantly associated with 
MI.  Furthermore, effects among women were similar to those seen among men.  
     As mentioned in 2.3.2, psychological distress measured by GHQ-12 and GHQ-30 has 
also been associated with cardiovascular mortality. However, some of these studies did 
not include women (163-165), or men and women were analyzed as one group (6). In 
women, Stansfeld et al. (2002) (162) reported statistically significant association of 
psychological distress measured by GHQ-30 with self-reported coronary heart disease, but 
not with ECG abnormalities. Using GHQ-12, Hamer et al. (2008) (7) reported similar 
effects of distress on CVD among men and women, but the statistical significance is not 
reported. Thus the existence of a possible gender difference is yet to be fully elucidated. 
2.3.3 The role of C-reactive protein (CRP) 
2.3.3.1 CRP and cardiovascular diseases 
Over the last 20 years, appreciation of the role of inflammation in atherosclerosis has 
grown, and atherosclerosis is now seen as an inflammatory process (8,9). After initiation of 
an atherogenic diet, arterial endothelial cells begin to express on their surface selective 
adhesion molecules that bind to various classes of leukocytes, which penetrate into the 
intima. Once resident in the arterial wall, they participate in and perpetuate a local 
inflammatory process, which releases local fibrogenic mediators that can inhibit collagen 
synthesis. This results in weakening of the fibrous cap above the growing plague, 
rendering it weak and susceptible to rupture (9). As an essential marker of inflammation, 
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hsCRP has also been evaluated as a potential tool for prediction of cardiovascular events. 
Indeed, more than 25 prospective population-based studies have shown a consistent and 
robust relationship between levels of hsCRP and the risk of future cardiovascular events, 
independent of traditional cardiovascular risk factors (e.g., age, blood pressure, serum 
cholesterol levels and smoking) (11,20,168-171). In the report by Ridger et al. (2000) (172), 
of the 12 markers measured (e.g., total cholesterol, LDL cholesterol and HDL cholesterol), 
hsCRP was the most powerful predictor of risk in the univariate analysis. In the Helsinki 
Heart Study of 4081 middle-aged men, hypertension and dyslipidemia increased the CVD 
risk only marginally without simultaneous occurrence of high CRP, whereas the joint 
effects of CRP and these classic risk factors suggested additive effects on coronary risk 
(173). In Cardiovascular Health Study with 5020 subjects without baseline CVD, when 
CRP was elevated (> 3 mg/L) among those with detectable atherosclerosis on ultrasound, 
there was a 72% increased risk for CVD death.  Elevated CRP in the absence of 
atherosclerosis did not increase CVD (174). As a result of these findings, the American 
Heart Association (AHA) and the Centers for Disease Control and Prevention (CDC) 
recommended in 2003 plasma levels of hsCRP <1mg/l, 1 to 3 mg/l and >3 mg/l as 
representing low, average or high relative cardiovascular risk, respectively, when added 
to traditional risk factors (11). 
2.3.3.2 Mediating role of CRP between psychological distress and CVD risk 
Inflammation has recently been posited as a candidate pathophysiological mechanism 
through which psychological factors are associated with CVD. Psychosocial stress 
primarily activates the hypothalamic pituitary adrenocortical axis and sympathetic 
nervous system, which can trigger pathophysiological mechanisms that include 
inflammation, hemostasis, and altered metabolic and cardiac autonomic control (175). It is 
reasonably to assume that inflammation could be a mediating factor between 
psychological factors and CVD, because of the robust association between psychological 
distress and inflammation (see 2.2) and between inflammation and CVD (see 2.3.3.1). 
However, there are only a few large scale studies that have investigated this proposed 
mediating role. In the PRIME study of healthy middle-aged men with 335 future CVD 
cases and 670 matched controls, the odds ratio of depressive mood for CVD was 1.50 after 
adjustment for social characteristics and classic cardiovascular risk factors (116). However, 
this association remained stable after further adjustment with CRP levels. The authors 
conclude that inflammation might not be primarily responsible for the association between 
depressive mood and CVD risk. In the WISE study of  527 women with suspected 
coronary ischemia, subjects with depression had significantly higher risk for CVD (HR 
2.65) after adjustment with age, education, marital status and traditional CVD risk factors. 
However, further adjustment with CRP decreased the estimate for depression only by 13% 
(HR 2.43) (112). Hamer et al. (2008) (7) used GHQ-12 in their study of 6576 healthy men 
and women. In an age- and gender-adjusted analysis, psychological distress (GHQ-12 
score ≥ 4) was associated with higher risk for CVD (OR 1.54). In models that were adjusted 
for potential mediators, behavioral factors explained the largest proportion of variance, 
whereas CRP accounted for only 5.5%.  In conclusion, although there is some evidence for 
the mediating role of CRP in the association between psychological factors and CVD risk, 
the independent role of CRP seems to be rather small.  
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2.4 METABOLIC SYNDROME (METS) AND PSYCHOLOGICAL DISTRESS 
2.4.1 Definitions and prevalence of MetS 
The metabolic syndrome (MetS) is a prevalent cluster of factors that increases the risk of 
cardiovascular diseases, type 2 diabetes mellitus and all-cause mortality (12,13). Despite 
general recognition of the syndrome, there has not been a uniform definition or diagnostic 
criteria for MetS. In 1998, the World Health Organization (WHO) proposed the first 
internationally accepted criteria for MetS (176). According to WHO definition, insulin 
resistance and hyperinsulinemia are the core of the syndrome, as well as central obesity. 
Dyslipidemia, elevated blood pressure and glucose intolerance are also included in the 
criteria. Another widely used definition of MetS is the one proposed by the International 
Diabetes Federation (IDF) (177). 
     The National Cholesterol Education Program (NCEP) – Adult Treatment Panel III 
published their diagnostic criteria for MetS in 2001 (178). This definition was based on 
fasting glucose, triglycerides, high-density lipoprotein (HDL) cholesterol, blood pressure 
and abdominal obesity with equal weight on each component. NCEP defines MetS as 
having three or more of the following criteria: 1) fasting serum glucose of 6.1 mmol/l (110 
mg/dl) or higher, or use of anti-diabetic medication, 2) serum triglycerides of 1.7 mmol/l 
(150 mg/dl) or higher, or use of cholesterol-lowering medication, 3) serum HDL 
cholesterol < 1.03 mmol/l (40 mg/dl) in men or  < 1.29 mmol/l (50 mg/dl) in women, 4) 
blood pressure of 130/85 mmHg or higher, or use of anti-hypertensive medication and 5) 
waist circumference > 102 cm in men or > 88 cm in women.  
     Understanding the mechanisms involved with MetS is of great importance given the 
pandemic of obesity and increasing prevalence of the metabolic syndrome. The age-
adjusted prevalence of MetS in the US population is estimated to be approximately 35% 
(179), using the NCEP criteria. A similar prevalence (37%) has been reported also in 
Eastern Finland, which is where this study was conducted (180). 
2.4.2 The association between psychological distress and MetS 
Cross-sectional studies on psychological factors and MetS have yielded mixed results. 
Some studies have found an association of MetS with depressive symptoms (180-185), 
whereas other studies have not (186-188). In some studies the association was observed 
only among women (189-191), in others only among men (192-194). Other psychological 
factors (e.g., general psychological distress, anxiety and stress) have been reported to be 
associated with MetS only in a handful of cross-sectional studies (195-199). 
     There are only a few prospective studies on psychological factors and MetS, and the 
findings are confined to depressive symptoms and chronic stress. Study by Vanhala et al. 
(2009) (200) yielded a significant association among women between depressive symptoms 
measured by the Beck depression inventory (BDI) and the development of MetS. After 
adjusting for age, socio-economic status, health behaviors and use of medication, a 2.5-fold 
risk (OR 2.5) was reported for women with depressive symptoms (BDI ≥10) at baseline to 
have MetS at the end of follow-up, compared to non-depressive women.  Among men, 
there was no risk difference. Conducted in a sample of middle-aged women, Räikkönen et 
al. (2007) (201) have reported relative risks of developing MetS varying from 1.21 to 2.12 
for severe depressive symptoms or very stressful life events over the 15-year follow-up, 
and results for tension, trait anger and perceived stress varied per criterion used to define 
MetS. In another study by the same authors (2002) (202), women who exhibited high levels 
of depression, tension, and anger at baseline had 1.29- to 1.47-fold risk of developing MetS 
during follow-up of 7.4 years. Also the study by Goldbacher et al. (2009) (203) included 
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only women as study subjects; in their study the odds ratio for MetS among women with 
lifetime history of major depression was 1.82 compared to non-depressive subjects. Pulkki-
Råback et al. (2009) (204) included 921 young adults (both men and women) in their study 
sample, but the relationship between depressive symptoms and MetS was significant only 
among women. Another two prospective studies have found an association between 
chronic stress and the development of MetS.  Vitaliano et al. (2002) (205) reported that in 
older adult men and women not receiving hormone replacement therapy, chronic stress 
over 15-18 months was associated with a factor composed of the components of MetS. In a 
study by Chandola et al. (2006) (206) conducted in a sample of London civil servants, 
greater exposure to job stress over 14 years was linked to greater risk of MetS in both men 
and women in a dose dependent manner. None of these studies found an association 
between symptoms of anxiety and risk of developing MetS; in each case, the association 
was either not studied or not found to be statistically significant. No prospective studies 
on psychological distress measured by the GHQ-12 and the occurrence of MetS has been 
published.  
2.4.3 Proposed mediating pathways between MetS and psychological distress 
There is increasing interest in the association between psychological factors and MetS, and 
whether causal relationships are involved. In a review by Goldbacher et al. (2007) (14), a 
model was proposed in which psychological factors may contribute to the pathogenesis of 
MetS via physiological and behavioral mediating pathways. In addition, demographic 
characteristics, such as gender, age and socio-economic status, may influence the 
association although the exact mechanism is unknown (14).  
2.4.3.1 Physiological pathways  
Main proposed physiological pathways between psychological factors and MetS include 
dysregulation of the sympathetic adrenal medullary (SAM) and hypothalamic pituitary 
adrenal (HPA) axes (207,208), which has been implicated in the development of MetS and 
its key component, insulin resistance (209). Björntorp suggested in 1997 (210,211) that 
elevated cortisol is the main manifestation of this dysregulation: psychological factors are 
associated with elevated cortisol, which in turn causes accumulation of fat in visceral 
adipose tissues as well as other metabolic abnormalities. Indeed, Vogelzangs et al. (2007) 
(181) have demonstrated that the risk for developing MetS in depressed subjects was 
higher for subjects with high cortisol as compared to subjects with no depression and low 
cortisol.  
2.4.3.2 Health behaviours 
As mentioned in 2.1.6, psychological distress has been associated with higher levels of 
smoking (6,74,87-90) and sedentary lifestyle (74,92-95). The relationship between high 
psychological distress measured by the GHQ-12 and alcohol consumption is controversial 
(7,74,96-98). On the other hand, MetS is associated with unhealthy behaviors, such as 
smoking and sedentary lifestyle (212), and there is growing evidence from prospective 
studies that lifestyle factors influence the risk for developing MetS (213,214). However, 
whether or not health behaviours are an independent pathway linking psychological 
distress and MetS, is yet to be fully elucidated. Physical activity has been reported to 
mediate the association between depressive symptoms and insulin resistance among 
women (215). There is also some support for the hypothesis that physical exercise may 
exert its beneficial effects on the occurrence of MetS not only by raising energy 
expenditure but also by buffering the relationship of psychological stress with obesity and 
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the metabolic syndrome (216). In the prospective, population-based Northern Finland 1966 
Birth Cohort Study, Herva et al. (2006) (186) reported that gender, smoking, alcohol 
consumption, marital status, level of education and physical activity mediated the 
association between depression and waist circumference. In a prospective study with 432 
healthy women, age, education, hormone replacement therapy, smoking, alcohol and 
physical activity attenuated the association of depressive symptoms with the risk of 
developing MetS (201). However, inclusion of these lifestyle and socioeconomic covariates 
simultaneously into the models in previous studies makes it difficult to draw conclusion 
on the independent role of health behaviours.  
2.4.4 The role of C-reactive protein (CRP) 
Inflammation is a recently purported physiological mechanism linking psychological 
distress to the development of MetS (15). As mentioned in 2.2, an association between 
psychological distress and elevated markers of inflammation has been reported (7,115). 
Inflammation is also a key component of MetS (127,217,218), and high CRP levels increase 
the risk of developing MetS. In the population-based Insulin Resistance Atherosclerosis 
Study with 1008 non-diabetic subjects, there was a linear increase in prevalence of 
metabolic disorders with increasing CRP levels (218). In the Mexico City Diabetes Study, 
515 men and 729  women, free of MetS at baseline, were followed for 6 years. Women with 
high CRP had a four-fold risk (OR 4.0) of developing MetS compared to women with low 
CRP (219). Among men, not significant association was observed. Indeed, some definitions 
of MetS now include CRP as an optional component of the syndrome (220).  
     There are no prospective studies about the possible mediating role of CRP in the 
association between psychological factors and the risk of developing MetS. Capuron et al. 
(2008) (192) reported in a cross-sectional study setting that after adjusting for age, 
education and smoking status, MetS was significantly associated with depressive 
symptoms. A further adjustment for CRP decreased the coefficient for MetS somewhat, 
but the association remained statistically significant. 
2.5 ALL-CAUSE MORTALITY AND PSYCHOLOGICAL DISTRESS 
Higher risk of premature all-cause mortality has been observed across a wide variety of 
mental disorders (16), also among the Finnish population (221). Depression has been 
associated with increased mortality in many population-based studies (222). In the meta-
analysis by Cuijpers et al. (2002) (223), the overall relative risk of dying in depressed 
subjects was 1.81 compared to non-depressed subjects. In addition, there were no major 
gender differences, and the relative risk in subthreshold depression was not smaller than 
the relative risk in clinical depression. Studies linking anxiety with increased all-cause 
mortality have yielded either positive (224), negative (225) or U-shaped (226) associations. 
     Community studies examining the effect of nonspecific psychological distress have 
found a relationship between high levels of distress and increased all-cause mortality. 
Somervell et al. (1989) (227) measured psychological distress by Health Opinion Survey in 
a 12-year follow-up study with 610 men and women, and reported 1.93-fold mortality risk 
for distressed subjects compared to non-distressed subjects after adjusting for age, gender 
and race. This pattern was not significantly affected by controlling for smoking, BMI and 
social class. In her mortality study of 120760 responders with psychological distress 
assessment using the K6, Pratt (2009) (228) reported an age- and gender-adjusted mortality 
hazard ratio of 2.2 with serious psychological distress. Including sociodemographic factors 
and health behaviours in the model decreased the hazard ratio slightly (1.90 and 1.52, 
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respectively), but the results remained statistically significant. Also U-shaped associations 
between psychological distress and all-cause mortality has been reported (229). 
     Most studies using the GHQ in its different forms indicate that there is excess all-cause 
mortality in distressed subjects compared to non-distressed subjects. In 1989, Anttila et al. 
(230) reported that in the population of 982 elderly living in a community in Northern 
Finland, the ten-year mortality was significantly higher (HR 1.4) in men and women with 
high GHQ scores compared to subjects with low GHQ scores, when the effects of age and 
certain diseases were controlled for. Huppert and colleagues (1995) (231) found that 
distressed subjects (GHQ-30) had a significantly increased mortality risk (1.60-fold for men 
and 1.42-fold for women, adjusted for age, smoking and social class) compared to non-
distressed subjects. Also Gunnel et al. (2002) (232) used the GHQ-30 and reported similar 
results: non-adjusted mortality hazard ratio for distressed was 1.27 for men and 1.12 for 
women. However, in the study by Rasul et al. (2004) (233), psychological distress was 
associated with 5 year all-cause mortality only among men. 
      There are only four prospective studies which have studied the association of 
psychological distress measured by GHQ-12 with all-cause mortality in the general 
population. Using the data from the nationally representative British Household Panel 
Survey with 1646 men and 2049 women, Gardner et al. (2004) (17) found a statistically 
robust positive association between psychological distress and female mortality, after 
controlling for age, marital status and education. Further adjustment for smoking made 
the results statistically non-significant. Among men, no such association was observed. In 
the population-based study by Robinson et al. (2004) (6), with 4501 adults, individuals 
reporting high levels of psychological distress (GHQ-12 score ≥ 4) had an age- and gender-
adjusted mortality hazard ratio of 1.75. After considering the influence of smoking, pain 
and deprivation, the hazard ratio diminished slightly (1.71), but remained statistically 
significant. In their prospective study of 6576 men and women from the Scottish Health 
Survey, Hamer et al. (2008) (7) reported a 1.88-fold risk for all-cause mortality among 
distressed subjects (GHQ-12 score ≥ 4) over an average of 7.2 years of follow-up (adjusted 
for age, gender and socioeconomic group).  They also studied the influence of various 
behavioral and pathophysiological risk factors in this association, including smoking, use 
of alcohol, sedentary lifestyle and obesity. Adjustments for these risk factors attenuated 
the association significantly (HR 1.36), collectively explaining 59% of the variance. In a 
larger population-based study by Hamer et al. (2010) (18), with 10280 non-diabetic subjects 
from both the Scottish Health Survey and the Health Survey for England, age and gender 
adjusted HR for subjects with high psychological distress (GHQ-12 score ≥ 4) was 3.12, 
compared to non-distressed subjects (GHQ-12 score 0). Further adjustment with 
socioeconomic group, smoking and physical activity attenuated the association somewhat 
(HR 2.47), but it remained statistically significant.  
2.5.1 The role of C-reactive protein (CRP) 
As mentioned in 2.2, an association between psychological distress and elevated markers 
of inflammation, such as CRP, has been reported (7,115). On the other hand, there is a 
robust relationship between high CRP concentration and increased CVD mortality (see 
2.3.3.1). In addition, CRP has also been shown to be related to all-cause mortality. In the 
MONICA/KORA Augsburg Cohort Study 1984-1998 with a study sample of 3620 middle-
aged men, subjects with hsCRP >3 mg/l at baseline showed an almost 2-fold increased risk 
to die compared to those with hsCRP <1 mg/l (19). Similar results have also been reported 
in Finland (20). This association has been observed also among women and there seems to 
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be a dose-response type of linear trend between higher hsCRP-levels and increasing 
mortality (21).  
     Physiological distress can alter the functioning of the hypothalamic pituitary 
adrenocortical (HPA) axis and sympathetic nervous system, which can trigger 
pathophysiological mechanisms that include inflammation, hemostasis, and altered 
metabolic and cardiac autonomic control (175). However, there is very limited data on the 
possible mediating role of CRP between psychological distress and all-cause mortality. In 
the above mentioned study of 6576 men and women by Hamer et al. (2008) (7), the 
reported 1.88-fold risk for all-cause mortality among distressed subjects (GHQ-12 score ≥ 
4, adjusted for age, gender and socioeconomic group) was attenuated significantly (HR 
1.36) after further adjusting with behavioral and pathophysiological risk factors, including 
CRP. All these factors explained collectively 59% of the variance, but the independent 
effect of CRP was not reported.  
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3 Aims of the study  
This study was undertaken to investigate the association of psychological distress, 
measured by the 12-item General Health Questionnaire (GHQ-12), with mortality and 
morbidity in a population-based study. 
 
The specific aims were: 
 
1. To examine the association of psychological distress with cardiovascular risk scores, 
and to establish whether such an association exists in both men and women. 
2. To study the relationship of psychological distress with C-reactive protein (CRP) 
representing high relative cardiovascular risk, and to establish whether such 
association remain significant after adjusting for potential mediators (behavioural and 
demographic variables). 
3. To examine whether psychological distress at baseline increases the risk of developing 
the metabolic syndrome (MetS) during follow-up, and what is the influence of 
sociodemographic variables, health behaviours and CRP in this association. 
4. To investigate whether psychological distress at baseline is associated with all-cause 
mortality during follow-up, and what is the influence of sociodemographic 
characteristics, behavioural variables and CRP in this association.  
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4 Subjects and methods 
4.1 SUBJECTS 
The study population consisted of middle-aged Caucasian subjects (n=1 294) born in 1942, 
1947, 1952, 1957 and 1962 in Pieksämäki, Finland. The age groups were recruited from the 
local population records by three separate invitations. No exclusion criteria were applied. 
Altogether, 923 (414 men and 509 women) of 1294 subjects (71.3%) participated in a cross-
sectional study from 1997-1998. In 2004-2005, 688 (74.5%) of the original 923 subjects took 
part in the 7-year follow-up visit. 
     The ethics committee of Kuopio University approved this study, and participants 
provided informed written consent. 
4.2 CLINICAL AND LABORATORY METHODS 
All measurements were done by the two trained nurses at Pieksämäki. Height and weight 
were measured to the nearest 0.5 cm and 0.1 kg, respectively. The BMI was calculated as 
kg/m2. The waist was measured at the midpoint between the lateral iliac crest and the 
lowest rib to the nearest 1.0 cm. Blood pressure was measured twice at 5 minute intervals 
with subjects in a sitting position after a 15-minute rest with a mercury 
sphygmomanometer. Readings from the second measurement were used in the analyses.  
     All participants completed a standard questionnaire, including questions regarding 
marital status, education, use of medication, smoking, use of alcohol, physical activity, 
depressive symptoms and psychological distress. Marital status was measured by a 
dichotomized variables (marriage or common law marriage vs. living alone). In study III, 
education was measured with a five-step variable (1=basic education only, 2=vocational 
education, 3=upper secondary school, 4=upper secondary school + vocational education 
and 5=higher education). In study IV, a dichotomized variable was formed [1=basic 
education or high school (basic education only, vocational education, upper secondary 
school), 2=college or university degree (upper secondary school + vocational education, 
higher education)] . Persons who smoked at least once a week were labeled as current 
smokers. Current use of alcohol was defined as alcohol consumption at least once a year. 
Leisure time physical activity was defined as physical exercise lasting at least 30 minutes 
per time and causing sweating. There were three categories: low activity (1-2 times a 
month or less), moderate activity (1-3 times a week) and high activity (more than 3 times a 
week).  Depressive symptoms were measured by Beck depression inventory (BDI). 
     Fresh serum samples were drawn after an overnight fast. Plasma was separated by 
centrifugation, and samples were frozen immediately at −70° C. Serum triglycerides, 
cholesterol and high-density lipoprotein (HDL) cholesterol were measured by enzymatic 
colorimetric methods.  hsCRP was measured with an Immulite 2000 analyser and a DPC 
high sensitivity CRP assay (Diagnostic Products Corporation, Los Angeles, California) 
with intra-assay CV of 2.8 – 8.7% and a sensitivity of 0.1 mg/l. The analysis was performed 
in 2003 from blood samples that were taken from the participants in 1997–1998 and stored 
at –70°C since that time.  
     In study I, the risk for CVD events was calculated using 1) the European SCORE model 
(143) with gender, age, smoking, systolic blood pressure and total cholesterol as variables, 
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and 2) the Framingham CVD risk prediction model by using the direct application of the 
Cox model (144). This model includes gender, age, total cholesterol, HDL cholesterol, 
systolic blood pressure, anti-hypertensive medication, smoking and diabetes as variables.  
     In the evaluation of MetS, the modified National Cholesterol Education Program – 
Adult Treatment Panel III criteria were used, with the 5.6 mmol/l (100 mg/dl) blood 
glucose cut-off point (220). Originally, NCEP defines MetS as having three or more of the 
following criteria: 1) fasting serum glucose of 6.1 mmol/l (110 mg/dl) or higher, or use of 
anti-diabetic medication, 2) serum triglycerides of 1.7 mmol/l (150 mg/dl) or higher, or use 
of cholesterol-lowering medication, 3) serum high-density lipoprotein (HDL) cholesterol < 
1.03 mmol/l (40 mg/dl) in men or  < 1.29 mmol/l (50 mg/dl) in women, 4) blood pressure of 
130/85 mmHg or higher, or use of anti-hypertensive medication and 5) waist 
circumference > 102 cm in men or > 88 cm in women (178).  
4.3 DEFINITION AND MEASUREMENT OF PSYCHOLOGICAL DISTRESS 
In this study, psychological distress was defined as a combination of depressive 
symptoms, anxiety and perceived stress. This is due to the nature of data on psychological 
distress used in this study, which was obtained with a self-reported scale and which 
therefore emphasises the subjective, affective experience of the study subjects.  
     Psychological distress was measured using the 12-item version on the General Health 
Questionnaire (GHQ-12). The rating method of the four-point response scale was the 
original GHQ method (0-0-1-1) (2). The points were summed to a global score ranging 
from 0-12.  In study I, subjects were allocated into three groups according to their GHQ-12 
scores (0 points, 1-2 points and 3-12 points) for illustrative purposes and in order to get as 
equal sized groups as possible. In studies II, III and IV, the cut-off point of 3/4 was used 
based in the study validating the GHQ-12 in the Finnish population (47). In study II,  three 
groups were defined representing low (0 points), medium (1-3 points) and high (4-12 
points) psychological distress. In studies III and IV, two groups were defined representing 
low (GHQ-12 score 0-3) and high (GHQ-12 score 4-12) psychological distress.   
     The GHQ-12 was chosen as a screening tool for psychological factors in this study for 
several reasons (see 2.1.2 and 2.1.3). First, the GHQ-12 was originally designed to be used 
this way in the community level. Second, it is a self-administrated questionnaire, which is 
beneficial in large population-based studies. Third, although there is conceptual 
overlapping with other instruments that screen e.g. depression, the GHQ-12 is a valid 
choice as an measurement of general psychiatric well-being because it also includes 
questions about perceived stress and anxiety.  
4.4 MORTALITY DATA 
Mortality data until 31 December 2009 were drawn from the national mortality register 
(Statistics Finland). This data was used in study IV.  
4.5 STATISTICAL ANALYSES  
All statistical analyses were performed using the SAS for Windows version 9.2 (SAS 
Institute Inc., Cary, NC, USA). The difference in mean GHQ-12 scores between genders 
was calculated using the Mann-Whitney test because of the very positively skewed 
distribution. The equality of distribution functions in men and in women was calculated 
with Kolmogorov-Smirnov test.  
23 
 
 
 
The factor structure of GHQ-12 was assessed by exploratory factor analysis with a 
maximum likelihood method for factoring and orthogonal (varimax) and oblique rotations 
on tetrachoric correlation matrix to indentify related items of the GHQ-12 questionnaire. 
The strategies used to extract the number of factors were 1) the Kaiser criteria, which 
determines that components with eigenvalues lower than one should be excluded and 2) 
the scree test of Cattell criteria. 
4.5.1 Study I 
Of the original 923 subjects from the cross-sectional study in 1997-1998, 24 subjects were 
lost from statistical analysis because of missing data, resulting a sample size of 899 subjects 
(399 men, 500 women). These 24 subjects had higher BMI compared to the study group, 
other differences were statistically insignificant. Results of the statistical analyses are 
expressed as mean with standard deviation (SD). The 95 per cent confidence intervals 
(95% CI) were obtained by bias-corrected bootstrapping (5000 replications). Statistical 
comparison between the genders was performed by t-test, bootstrap-type t-test (5000 
replications), permutation test or chi-square test, when appropriate. Statistical significance 
for the hypotheses of linearity was evaluated by a bootstrap-type ANCOVA. Correlation 
coefficients were calculated by the Pearson method with bias-corrected bootstrap 
confidence intervals. 
4.5.2 Study II 
In study II, according to current guidelines by CDC/AHA (234), an additional 16 subjects 
(6 men and 10 women) were excluded whose hsCRP concentration was ≥ 10.0 mg/l in 
order to eliminate possible cases of acute infections and other occult diseases, leaving a 
total of 883 subjects (393 men and 490 women). Results of the statistical analyses are 
expressed as mean with standard deviation (SD). Statistical significance for hypotheses of 
linearity was evaluated by bootstrap-type analysis of variance (ANOVA) (5000 
replications) due to the violation of  the assumptions or Cochran-Armitage trend test. 
Multivariate logistic regression was used to estimate odds ratios (OR) and their 95% CI. 
4.5.3 Study III 
For study III, a cohort was formed. In 2004-2005, 688 (74.5%) of the original 923 subjects 
took part in the 7-year follow-up visit. Of these 688 subjects, 22 were excluded from the 
analyses because of missing data. An additional 200 participants were excluded because 
they had MetS at baseline. Although these 200 subjects did differ from the study group 
with regard to age (the excluded were on average 2 years older), no other differences were 
observed.  Thus, the actual study sample in study III consisted of 466 subjects (185 men 
and 281 women) who did not have MetS at baseline. 
     Results are expressed as mean with standard deviation (SD). Statistical significance 
between groups was evaluated by t-test, bootstrap-type t-test or Chi-Square test. The 
internal consistency of the GHQ-12 was analyzed by Crohnbach’s α. Logistic regression 
was used to model the occurrence of the metabolic syndrome across follow-up. 
Occurrence of MetS was calculated with 95% confidence intervals, assuming a Poisson 
distribution. Standardized estimates of incidence rate ratio (IRR) for MetS were calculated 
using the Poisson regression model. Correlations were estimated by Spearman’s 
correlation coefficient method and 95% confidence intervals obtained by bias corrected 
bootstrapping. 
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4.5.4 Study IV 
The sample size in study IV consisted all the 923 subjects from the cross-sectional study 
from 1997-1998. Statistical significance between groups was evaluated by t- test or chi-
square test. Survival analysis was based on the Kaplan-Meier estimate of the survival 
function. Cox proportional hazards model was used to estimate adjusted risk for mortality 
between groups. The proportional hazard assumptions were tested using Schoenfeld 
residuals and natural logarithm of follow-up time. 
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5 Results 
5.1 CHARACTERISTICS OF THE STUDY SUBJECTS 
The distribution of baseline characteristics of the entire study population of 923 subjects 
(414 men and 509 women) are shown in Table 3. It can be seen that among women there 
are more subjects with higher education level, more current smokers, less current alcohol 
users and less subjects on cholesterol lowering or anti-diabetic medication. Women also 
had generally more beneficial CVD risk profile.  
 
 
 
 
Figure 1. Distribution of GHQ-12 scores (ranging from 0-12) by gender in the entire study 
population (n=923) 
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Table 3. Distribution of baseline characteristics of the entire study population (n=923) by 
gender. 
 
 
Male 
(n=414) 
Female 
(n=509) 
p value 
Age in years, mean (SD) 46 (6) 46 (6) 0.57 
Marriage or common law, n (%) 343 (83) 404 (79) 0.18 
Educational status, n (%)   <0.001 
   Basic education 55 (13) 54 (11)  
   Vocational education 129 (31) 139 (27)  
   Upper secondary school 138 (33) 119 (24)  
   Upper secondary school and 
   vocational education 70 (17) 153 (30)  
   Higher education 22 (5) 42 (8)  
Current smoker, n (%) 145 (35) 121 (24) <0.001 
Current use of alcohol, n (%)  359 (87) 405 (80) 0.005 
Leisure time physical activity, n (%)   0.80 
   Low 57 (14) 72 (14)  
   Moderate 229 (55) 290 (57)  
   High 128 (31) 147 (29)  
Body Mass Index, kg/m², mean (SD) 27 (4) 26 (5) 0.43 
Waist circumference, cm, mean (SD) 94 (11) 84 (13) <0.001 
Blood pressure, mmHg, mean (SD)    
   Systolic 138 (18) 133 (18) <0.001 
   Diastolic 84 (10) 80 (9) <0.001 
Plasma glucose, mmol/l, mean (SD) 6.0 (0.9) 5.6 (0.6) <0.001 
Total cholesterol, mmol/l, mean (SD) 5.8 (1.1) 5.7 (1.0) 0.03 
HDL cholesterol, mmol/l, mean (SD)       1.3 (0.3) 1.5 (0.3) <0.001 
Triglycerides, mmol/l, mean (SD) 1.7 (1.3) 1.2 (0.6) <0.001 
hsCRP, mg/l, mean (SD) 1.7 (3.4) 1.7 (2.3) 0.74 
Medication, n (%)    
   Anti-hypertensive medication 44 (11) 46 (9) 0.42 
   Cholesterol-lowering medication 15(4) 6 (1) 0.01 
   Anti-diabetic medication 10 (2) 4 (1) 0.04 
High distress (GHQ-12 ≥ 4),  n (%) 64 (16) 102 (20) 0.07 
 
GHQ-12 = 12-item General Health Questionnaire 
HDL = high density lipoprotein; hsCRP = high-sensitivity C-reactive protein 
Leisure time physical activity (min. 30 minutes) = Low: < 1 time/week, Moderate: 1-3 times/week, High: 
>3 times/week 
Plasma glucose = after an overnight fast 
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Figure 1 shows the distribution of GHQ-12 scores by gender. It can be seen that the 
distribution is very positively skewed. 55% of subjects scored 0 points. The equality of 
distribution functions did not differ between genders (p=0.34). There was also no 
significant difference in the mean GHQ-12 scores among men and among women. The 
distribution of individual GHQ-12 items is illustrated in Figure 2. Question 5 yielded most 
positive answers (Have you recently felt constantly under strain?), followed by question 9 
(Have you recently been feeling unhappy and depressed?). There was no significant 
difference between genders in any of the GHQ-12 items after adjusted multiple 
comparisons (Bonferroni correction).  
     The internal consistency of the GHQ-12 was good (Cronbach’s α = 0.90). When the 
factor analysis was performed, the GHQ-12 loaded only in one factor (Figure 3). Thus, 
GHQ-12 was considered to be a unidimensional measure in this study.  
 
 
 
 
 
Figure 2. Distribution of GHQ-12 items by gender in the entire study population (n=923) 
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Figure 3. Scree plot of Cattell criteria  
5.2 GENDER-SPECIFIC ASSOCIATION OF PSYCHOLOGICAL DISTRESS 
WITH CARDIOVASCULAR RISK SCORES (STUDY I) 
The sample size in study I comprised 899 subjects (399 men, 500 women) for whom 
information on psychological distress and clinical and biochemical variables was available. 
Table 4 shows the baseline characteristics of the subjects.  Age and BMI distributions were 
similar in both genders.  There were more current smokers among men than women and 
men had higher systolic and diastolic blood pressure. The levels of total cholesterol, 
triglycerides and fasting plasma glucose were significantly lower in women, whereas 
mean HDL cholesterol level was higher. There was no gender difference in the use of 
medication.  
     Initial analyses of psychological distress were calculated using the GHQ score as a 
continuous variable. The mean GHQ score for women was 1.9 (SD 3.1) and for men 1.5 
(SD 2.5), the difference was 0.5 (95% CI: 0.1 to 0.8) (p =0.014; after age-adjustment p=0.011). 
An interaction effect between gender and psychological distress was identified regarding 
both European CVD score (p <0.001) and Framingham CVD risk (p =0.013), justifying a 
further subgroup analysis by gender. In men, a significant correlation was identified 
between GHQ and both European CVD score [0.19 (95% CI 0.08 to 0.32)] and Framingham 
CVD risk [0.15 (CI 0.05 to 0.26)]. In women, correlations were not significant [0.09 (95% CI 
-0.01 to 0.20) and 0.06 (CI -0.05 to 0.18), respectively]. 
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Table 4. Demographic, clinical and biochemical characteristics and use of medication of the 
study subjects (n=899, Study I). 
 
Characteristics Male
(n=399) 
Female
(n=500) 
p value 
Demographic:    
      Age, mean (SD), years 46 (6) 46 (6) 0.61 
      Body mass index, mean (SD), kg/m2 26.6 (3.7) 26.4 (5.2) 0.42 
      Smoking, n (%) 136 (34) 112 (22) <0.001 
Clinical:    
   Blood pressure, mean (SD), mmHg: 
      Systolic  
      Diastolic 
 
137 (17)        
84 (10) 
 
131 (18) 
80 (10) 
 
<0.001 
<0.001 
Biochemical:    
   Total cholesterol, mean (SD), mmol/l 5.8 (1.1) 5.7 (1.0) 0.02 
   HDL cholesterol, mean (SD), mmol/l  1.3 (0.3) 1.5 (0.3) <0.001 
   Total triglycerides, mean (SD), mmol/l 1.7 (1.3) 1.2 (0.6) <0.001 
   Fasting plasma glucose, mean (SD), mmol/l 6.0 (0.9) 5.7 (0.6) <0.001 
Medication, n (%)    
   Anti-hypertensive medication 41 (10) 43 (9) 0.39 
   Cholesterol-lowering medication 12 (3) 6 (1) 0.06 
   Anti-diabetic medication 32 (8) 26 (5) 0.09 
 
 
For illustrative purposes, the study subjects were further allocated into three groups 
according to their GHQ score: 224 (56%) men and 273 (55%) women scored 0 points, 92 
(23%) men and 96 (19%) women scored 1-2 points and 83 (21%) men and 131 (26%) women 
scored 3-12 points.  
     The association of GHQ with both the European CVD risk score and the Framingham 
CVD risk divided by gender is illustrated in Figure 4. A relationship of psychological 
distress with cardiovascular risk scores was identified in men. Those in the highest group 
(3-12 points) had significantly higher mean European CVD risk score [3.6 (SD 3.3)] 
compared to men in the lowest group (0 points) [2.5 (SD 2.6)]. The difference between the 
groups was 1.1 (95% CI 0.4 to 1.9). The p value for linearity between the three GHQ groups 
was 0.003. The Framingham CVD risk prediction model yielded similar results: 15.7 (SD 
10.2) for the highest and 12.3 (SD 9.6) for the lowest GHQ group, the difference being 3.4 
(95% CI 1.0 to 6.0). The p value for linearity was 0.008.  
     In women, no significant association was observed. The mean European CVD risk 
scores for the highest and the lowest GHQ groups were 0.7 (SD 0.8) and 0.5 (SD 0.6), 
respectively. The difference between the groups was 0.1 (95% CI -0.1 to 0.3) and the p 
value for linearity between the three GHQ groups was 0.64. The mean Framingham CVD 
risk scores for women were 6.7 (SD 6.4) vs. 6.2 (SD 5.4), the difference being 0.5 (95% CI -
1.0 to 1.8). The p value for linearity was 0.45. 
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Figure 4. Gender-specific association of GHQ-12 with European CVD score and Framingham 
CVD risk. Whiskers show 95 percent confidence intervals (Study I). 
5.3 PSYCHOLOGICAL DISTRESS AND C-REACTIVE PROTEIN (STUDY II) 
In study II,  an additional 16 subjects (6 men and 10 women) were excluded whose hsCRP 
concentration was ≥ 10.0 mg/l in order to eliminate possible cases of acute infections and 
other occult diseases, leaving a total sample size of 883 (393 men and 490 women). 
     The mean global GHQ score for women was higher than for men [1.9 (SD 3.1) vs. 1.5 
(SD 2.5), p =0.014; after age-adjustment p=0.011]. The study subjects were allocated into 
three groups representing low, medium and high psychological distress status, according 
to their global GHQ score: 486 (55%) scored 0 points, 238 (27%) scored 1-3 points and 159 
(18%) scored 4-12 points.  
      Table 5 shows the distribution of the baseline factors of the 883 (393 men and 490 
women) subjects, according to psychological distress status.  Subjects with low 
psychological distress (0 points in GHQ-12) were younger and more physically active, and 
their mean hsCRP level was lower compared to subjects with medium (1-3 points) or high 
(4-12 points) psychological distress [1.26 (SD 1.36) mg/l, 1.53 (SD 1.75) mg/l and 1.70 (SD 
1.68) mg/l respectively, p for linearity = 0.003]. Psychological distress status was also 
significantly associated with hsCRP levels representing high relative cardiovascular risk 
(hsCRP > 3 mg/l). In groups representing low, medium and high psychological distress, 
the percentage of subjects having hsCRP > 3 mg/l was 11.3%, 13.9% and 17.6%, 
respectively ( p for linearity = 0.039). No significant relationship was found in regard to 
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Table 5. Distribution of baseline factors by psychological distress status (n=883, Study II). 
 
 Psychological distress (GHQ-12) p value 
for 
linearity  Low (0) n=486 Medium (1-3) 
n=238 
High (4-12) 
n=159 
Female, n (%) 266 (55) 125 (53) 99 (62) 0.20a 
Age in years, mean (SD) 45.6 (6.1) 45.4 (6.2) 47.4 (6.6) 0.002b 
Body Mass Index, kg/m², mean (SD) 26.4 (4.6) 26.5 (4.4) 26.4 (4.5) 0.79 b 
Waist circumference, cm, mean (SD) 87.5 (11.9) 88.3 (13.2) 87.9 (12.5) 0.66 b 
Current smoker, n (%) 131 (27) 67 (28) 48 (30) 0.43 a 
Current use of alcohol, n (%)  413 (85) 193 (81) 126 (79) 0.065 a 
Leisure time physical activity, n (%)     
   Low 53 (11) 38 (16) 32 (20) 0.002 a 
   Moderate 281 (58) 130 (55) 87 (55)  
   High 151 (31) 70 (29) 50 (25)  
Plasma glucose, mean (SD), mmol/l 5.8 (0.6) 5.8 (0.6) 5.7 (0.6) 0.68 b 
Metabolic syndrome present, n (%) 149 (31) 79 (33) 42 (26) 0.51 a 
Blood pressure, mmHg, mean (SD)     
   Systolic 133 (17) 133 (17) 134 (19) 0.65 b 
   Diastolic 81 (10) 81 (10) 82 (10) 0.52 b 
Total cholesterol, mmol/l, mean (SD) 5.7 (1.0) 5.7 (1.1) 5.7 (1.1) 0.93 b 
HDL cholesterol, mmol/l, mean (SD)       1.4 (0.3) 1.4 (0.3) 1.4 (0.3) 0.27 b 
Triglycerides, mmol/l, mean (SD) 1.4 (0.9) 1.5 (1.3) 1.3 (0.8) 0.14 b 
hsCRP, mg/l, mean (SD) 1.26 (1.36) 1.53 (1.75) 1.70 (1.68) 0.003 b 
     hsCRP >3 mg/l, n (%) 55 (11) 33 (14) 28 (18) 0.039 a 
 
GHQ-12 = 12-item General Health Questionnaire  
Leisure time physical activity (min. 30 minutes) = Low: < 1 time/week, Moderate: 1-3 times/week, High: 
>3 times/week 
Plasma glucose = after an overnight fast 
HDL = high density lipoprotein 
hsCRP = high-sensitivity C - reactive protein 
a Cochran-Armitage trend test 
b Bootstrap-type analysis of variance (ANOVA) with linear contrast 
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hsCRP = high-sensitivity C-reactive protein level representing low (<1 mg/l), average (1-3 mg/l) and high (>3 mg/l) 
relative cardiovascular risk 
 
Figure 5. The association of C-reactive protein level with psychological distress by gender. 
Whiskers show 95 percent confidence intervals (Study II). 
 
 
gender, BMI, waist circumference, smoking status, use of alcohol, blood pressure or serum 
cholesterol and fasting plasma glucose levels. There was also no difference in the 
prevalence of metabolic syndrome.  
     There was a similar linear trend in both genders between hsCRP levels representing 
low (<1 mg/l), average (1-3 mg/l) and high (>3 mg/l) cardiovascular risk, and increasing 
mean GHQ-12 score (Figure 5). When both genders were analyzed together, the linear 
association was statistically significant (p=0.012, adjusted for gender, age and BMI). Figure 
6 shows the estimated probability of high cardiovascular risk by GHQ-12 score by using 
the GHQ-12 as a continuous variable. It can be seen that the odds increase steeper per 
GHQ-12 point in men compared to women. However, no statistically significant 
interaction effect with gender was identified (p=0.63) and no further subgroup analyses by 
gender were performed.  
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Figure 6. Estimated probability of CRP concentration representing high relative cardiovascular 
risk (hsCRP > 3 mg/l) across follow-up by GHQ-12 score and gender. This curve is obtained by 
logistic regression model (Study II). 
 
In univariate logistic regression analysis, psychological distress and BMI were 
significantly associated with elevated hsCRP concentration representing high relative 
cardiovascular risk (>3.00 mg/l) (Table 6). The association between elevated hsCRP levels 
and psychological distress remained significant also in multivariate analysis after 
adjusting for gender, age, BMI, smoking, use of alcohol and leisure time physical activity. 
Odds-ratios for elevated hsCRP levels in the groups representing medium and high 
psychological distress were 1.32 (95% CI: 0.81 to 2.16) and 1.79 (95% CI: 1.05 to 3.04), 
respectively, compared with the group representing low psychological distress; p for 
linearity between the three groups was 0.032. BMI was also significantly associated with 
elevated hsCRP concentration in this model. 
 
GHQ-12 score
0 1 2 3 4 5 6 7 8 9 10 11 12
E
st
im
at
ed
 p
ro
ba
bi
lit
y 
of
 h
sC
R
P
 >
 3
0,05
0,10
0,15
0,20
0,25
0,30
Female
Male
34 
 
 
Table 6. Univariate and multivariate logistic regression to examine the association of 
demographic and behavioural characteristics with elevated C-reactive protein level (hsCRP > 3 
mg/l) (Study II). 
 
 Univariate analysis Multivariate analysis 
 OR (95% CI)  p value  OR (95% CI)  p value  
Male 0.76 (0.51 to 1.14) 0.19 0.74 (0.48 to 1.14) 0.18 
Age in years 1.02 (0.99 to 1.06) 0.13 1.01 (0.98 to 1.04) 0.56 
Body Mass Index, kg/m² 1.17 (1.13 to 1.23) <0.001 1.18 (1.13 to 1.23) <0.001 
Current smoker 1.19 (0.78 to 1.82) 0.41 1.28 (0.81 to 2.02) 0.29 
Current use of alcohol 0.99 (0.59 to 1.66) 0.97 1.14 (0.65 to 1.99) 0.65 
Leisure time physical activity  0.86a  0.45a 
   Low 1 (reference)b  1 (reference)b  
   Moderate 1.15 (0.73 to 1.80)  1.14 (0.71 to 1.84)  
   High 0.99 (0.52 to 1.91)  0.66 (0.32 to 1.36)  
Psychological distress (GHQ-12)  0.041a  0.032a 
   Low (0) 1 (reference)b  1 (reference)b  
   Medium (1-3) 1.26 (0.79 to 2.00)  1.32 (0.81 to 2.16)  
   High (4-12) 1.67 (1.02 to 2.75)  1.79 (1.05 to 3.04)  
 
Leisure time physical activity (min. 30 minutes) = Low: < 1 time/week, Medium: 1-3 times/week, High: 
>3 times/week 
GHQ-12 = 12-item General Health Questionnaire  
a p value for linearity 
b Denominator (reference group) of following odds ratios 
5.4 PSYCHOLOGICAL DISTRESS AND THE DEVELOPMENT OF THE 
METABOLIC SYNDROME (STUDY III) 
Study III was a prospective study from 1997-1998 to 2004-2005, with 466 (185 men and 281 
women) subjects free of the metabolic syndrome at baseline, and for whom information on 
psychological distress and necessary clinical and biochemical variables was available.  
    The mean baseline GHQ-12 score of the 466 subjects was 1.7 (SD 2.9). Among these 
subjects, 380 (82%) scored 0-3 points (low psychological distress) and 86 (18%) scored 4-12 
points (high psychological distress). Table 7 shows the distribution of baseline factors 
according to psychological distress status.  Subjects with low psychological distress were 
younger and more physically active compared to subjects with high psychological distress 
and their marital status was more often marriage or common law marriage. There was a 
significantly larger proportion of women in the group representing high psychological 
distress compared to the low distress group (70% vs. 58%, p=0.047). No significant 
differences between the psychological distress groups were found with regard to 
educational status, smoking status, use of alcohol, BMI, hsCRP levels or use of anti-
hypertensive, cholesterol lowering or anti-diabetic medication. There was also no 
difference in the variables defining MetS (waist circumference, blood pressure, fasting 
plasma glucose, HDL cholesterol and triglycerides).  
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Table 7. Distribution of baseline factors by psychological distress status (n=466, Study III). 
 
 
Psychological distress (GHQ-12)  
 
Low (0-3)  
n=380 
High (4-12) 
n=86 
p value 
Female, n (%) 221 (58) 60 (70) 0.047 
Age in years, mean (SD) 45 (6) 48 (7) 0.003 
Marriage or common law, n (%) 322 (85) 60 (70) 0.001 
Educational status, n (%)   0.11 
   Basic education 26 (7) 10 (12)  
   Vocational education 108 (29) 23 (27)  
   Upper secondary school 119 (31) 23 (27)  
   Upper secondary school and 
   vocational education 103 (27) 19 (22)  
   Higher education 23 (6) 11 (13)  
Current smoker, n (%) 98 (26) 22 (26) 0.97 
Current use of alcohol, n (%)  325 (86) 70 (81) 0.34 
Leisure time physical activity, n (%)   0.030 
   High 125 (33) 20 (23)  
   Moderate 212 (56) 48 (56)  
   Low 43 (11) 18 (21)  
Body Mass Index, kg/m², mean (SD) 24.7 (2.9) 24.8 (3.0) 0.75 
Waist circumference, cm, mean (SD) 83 (9) 83 (10) 0.83 
Blood pressure, mmHg, mean (SD)    
   Systolic 129 (16) 128 (16) 0.44 
   Diastolic 78 (9) 79 (9) 0.85 
Plasma glucose, mmol/l, mean (SD) 5.6 (0.5) 5.6 (0.6) 0.37 
Total cholesterol, mmol/l, mean (SD) 5.6 (0.9) 5.7 (0.9) 0.52 
HDL cholesterol, mmol/l, mean (SD)       1.5 (0.3) 1.5 (0.3) 0.62 
Triglycerides, mmol/l, mean (SD) 1.1 (0.5) 1.1 (0.5) 0.58 
hsCRP, mg/l, mean (SD) 1.3 (2.1) 1.7 (2.7) 0.19 
Medication, n (%)    
   Anti-hypertensive medication 21 (6) 7 (8) 0.36 
   Cholesterol-lowering medication 3 (1) 0 (0) 0.98 
   Anti-diabetic medication 0 (0) 0 (0)  
BDI score, mean (SD) 2.6 (3.0) 11.8 (7.5) <0.001 
 
GHQ-12 = 12-item General Health Questionnaire; HDL = high density lipoprotein; hsCRP = high-
sensitivity C-reactive protein; BDI = Beck Depression Inventory 
Leisure time physical activity (min. 30 minutes) = Low: < 1 time/week, Medium: 1-3 times/week, High: 
>3 times/week 
Plasma glucose = after an overnight fast 
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Figure 7. Estimated probability of developing the metabolic syndrome across follow-up by 
GHQ-12 score at baseline. The shaded region shows 95% confidence intervals. This curve is 
obtained by logistic regression model (Study III). 
 
 
 
The mean observation time in this prospective study was 6.4 years, ranging from 5.3 to 7.4 
years. During the observation of 2991 person-years, 101 subjects (22%) developed MetS. 
The occurrence rate of MetS was 34 (95% CI 28 to 41) per 1000 person-years [34 (95% CI 24 
to 46) for men and 34 (95% CI 26 to 43) for women, p=0.93]. 
     The mean global GHQ score was significantly higher among the 101 subjects who 
developed MetS during the observation period compared to the 365 subjects who did not 
[2.4 (SD 3.4) vs. 1.5 (SD 2.6), p=0.010]. There was a positive trend between GHQ-12 score at 
baseline and increasing estimated probability of developing MetS across follow-up (Figure 
7).  The risk increased by 10% for every GHQ-12 point [OR 1.10 ( 95% CI 1.02 to 1.18, 
p=0.009)].  In groups representing low (GHQ 0-3) and high (GHQ 4-12) psychological 
distress, the occurrence rates of MetS were 30 (95% CI 23 to 37) per 1000 person-years and 
52 (95% CI 35 to 75) per 1000 person-years, respectively. Because no interaction effect with 
gender was identified (p=0.68), no further subgroup analyses by gender were performed. 
The age- and gender-adjusted incidence rate ratio (IRR) between the groups was 1.56 (95% 
CI 1.05 to 2.43), p=0.048.  
     Table 8 shows the results of a series of multivariate logistic regression models assessing 
the relationship between various baseline factors and the occurrence of the metabolic 
syndrome. Subjects with high psychological distress at baseline were more than twice as 
likely to develop MetS as those with low psychological distress. When also age, gender 
and socio-demographic variables (marital status and educational status) were included in 
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the analysis (model 2), the odds of MetS in the distressed group was somewhat 
diminished, but remained highly significant. Age was also associated with the 
development of MetS in this model, whereas gender, marital status and educational status 
were not. Adjusting for health behaviors (smoking, use of alcohol and leisure time 
physical activity) did not significantly change the above-mentioned associations (model 3), 
although current smoking was significantly associated with increasing risk of MetS. 
Finally, C-reactive protein was included in the analysis (model 4), which had a very minor 
effect on the odds ratios of other factors. In this full-adjusted model, the odds ratio of 
developing MetS in the group representing high psychological distress was 1.81 (95% CI 
1.03 to 3.18, p=0.038) compared to the group representing low psychological distress. In 
this fully adjusted model, age and current smoking were also significantly associated with 
the occurrence of MetS, whereas gender, use of alcohol, leisure time physical activity and 
hsCRP level did not have a statistically significant effect. 
     The GHQ-12 scores were highly correlated with BDI depression scores: Spearman's rho 
= 0.67 (95% CI 0.62 to 0.73), and there was no gender difference in this association (rho = 
0.67 among men, rho = 0.67 among women). When both the GHQ-12 and the BDI scores 
were included in the multivariate logistic regression models as presented in Table 8, none 
of the associations was statistically significance (p GHQ = 0.40; p BDI = 0.29). This finding 
resulted from the strong collinearity of the GHQ-12 and the BDI. 
     Among individual components of MetS (Figure 8), high psychological distress was a 
significant predictor of risk compared to low psychological distress for meeting the NCEP 
criteria in low HDL cholesterol and waist circumference [OR 2.42 (95% CI 1.40 to 4.18) and 
1.85 (95% CI 1.09 to 3.14), respectively]. Adjusting the odds ratios with corresponding 
measures at baseline did not significantly change the results. 
3
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NCEP criteria: Gluc = fasting serum glucose of 5.6 mmol/l (100 mg/dl) or higher, TG = serum triglycerides of 1.7 
mmol/l (150 mg/dl) or higher, HDL-chol = serum high-density lipoprotein (HDL) cholesterol < 1.03 mmol/l (40 mg/dl) 
in men or  < 1.29 mmol/l (50 mg/dl) in women, RR = blood pressure of 130/85 mmHg or higher, Waist = waist 
circumference > 102 cm in men or > 88 cm in women.  
 
Figure 8. The odds ratio of meeting individual criterion of the metabolic syndrome in the high 
distressed group (GHQ 4-12) compared to the low distressed group (GHQ 0-3). White boxes 
represent  unadjusted values, black boxes values adjusted with corresponding measure at 
baseline. Whiskers show 95 percent confidence intervals (Study III). 
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5.5 PSYCHOLOGICAL DISTRESS AND ALL-CAUSE MORTALITY (STUDY 
IV) 
The sample size in study IV consisted all the 923 subjects from the cross-sectional study 
from 1997-1998. The mortality data of these subjects until 31 December 2009 were drawn 
from the national mortality register (Statistics Finland). 
     The mean GHQ score for women was 1.9 and for men 1.5 (p=0.01). There were 757 (82 
%) non-distressed and 166 (18 %) distressed subjects at baseline. Table 9 shows the 
distribution of baseline factors according to psychological distress status. Subjects with 
psychological distress were older, less physically active and lived more often alone. The 
psychological distress groups did not differ with regard to gender, BMI, CRP 
concentration, level of education or smoking status.  
 
Table 9. Distribution of baseline factors by psychological distress status (n=923, Study IV). 
 
 
Psychological distress (GHQ-12)  
 
No distress (0-3) 
n=757 
Distressed (4-12) 
n=166 
p value 
Female, n (%) 407 (54) 102 (61) 0.072 
Age in years, mean (SD) 46 (6) 47 (7) 0.001 
Body Mass Index, kg/m², mean (SD) 26.6 (4.6) 26.5 (5.0) 0.92 
hsCRP, mg/l, mean (SD) 1.7 (2.9) 2.0 (2.6) 0.18 
Living alone, n (%) 132 (17) 44 (27) 0.007 
Level of education, n (%)   0.39 
   Basic education or high school 517 (68) 119 (72)  
   College or university degree 240 (32) 47 (28)  
Current smoker, n (%) 216 (29) 50 (30) 0.68 
Leisure time physical activity, n (%)   0.022 
   Low 95 (12) 34 (21)  
   Moderate 429 (57) 90 (54)  
   High 233 (31) 42 (25)  
 
 
GHQ-12 = 12-item General Health Questionnaire; hsCRP = high-sensitivity C-reactive protein 
Leisure time physical activity (min. 30 minutes) = Low: < 1 time/week, Moderate:1-3 times/week, High: 
>3 times/week 
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The mean follow-up period was 11 years. There were 44 death events (27 men, 17 women), 
and the most common causes were cardiovascular diseases (ICD-10 codes I21 to I69, 14 
deaths), cancer (C16 to C71, 9 deaths), suicides (X61 to X73, 4 deaths) and accidents (V43 to 
X59, 4 deaths). Causes for death were similar in both genders. When the GHQ score was 
used as a continuous variable, the hazard ratio (HR) increased by 16% for every GHQ-12 
point (HR 1.16, 95% CI: 1.08-1.25, p<0.001). Table 10 shows the results of a series of Cox 
proportional hazards models including adjustments with various baseline factors. It can be 
seen that the HR per GHQ-12 point decreased only slightly with additive adjustments 
with gender and age [1.16 (1.07-1.25)], BMI [1.16 (1.07-1.25)], socioeconomic status [1.14 
(1.05-1.24)], and smoking and physical activity [1.13 (1.04-1.22)]. In the fully adjusted 
model, HRs for gender [2.06 (1.09-3.88)], age [1.14 (1.07-1.21)] and current smoking [1.90 
(1.02-3.54)] were also significant.  
 
 
Figure 9. Kaplan-Meier estimates of non-distressed (GHQ-12 score 0-3) and distressed (GHQ-
12 score 4-12) subjects, divided by gender (Study IV). 
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When the GHQ-12 score was categorized (non-distressed = 0-3 points, distressed = 4-12 
points), the 10-year survival for distressed was 91% (95% CI: 85-94) and for non-distressed 
97% (95% CI: 95-98), HR = 2.42 (95% CI: 1.30-4.52, p=0.005). Figure 9 shows the survival 
estimates separately for men and for women. In men, the 10-year survival for distressed 
was 84% (95% CI: 73-91) and for non-distressed 96% (95% CI: 93-97), HR = 3.38 (95% CI: 
1.55-7.39, p=0.002). Among women, the survival rates for distressed and non-distressed 
were 95% (87-97) and 98% (95-99), respectively, HR = 1.69 (0.59-4.79, p=0.33). There was a 
statistically significant age-adjusted interaction effect between gender and psychological 
distress (p=0.007), but due to small number of death events among women, no further 
gender stratified adjustments with socioeconomic or behavioural variables could be done.  
     In Cox regression analysis, CRP level was not associated with all-cause mortality. Age 
and gender adjusted HR per mg/l was 1.05 (95% CI: 0.98-1.11, p=0.15).  
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6 Discussion 
6.1 PIVOTAL FINDINGS 
According to this study, there is a gender-specific association of psychological distress 
with the CVD risk scores. Men in the highest GHQ group (GHQ-12 points 3-12) had 
significantly higher mean European CVD risk score [3.6 (SD 3.3)] compared to men in the 
lowest group (0 points) [2.5 (SD 2.6)], the difference being 1.1 (95% CI 0.4 to 1.9). The p 
value for linearity between the three GHQ groups was 0.003. The Framingham CVD risk 
prediction model yielded similar results: 15.7 (SD 10.2) vs. 12.3 (SD 9.6), the difference 3.4 
(95% CI 1.0 to 6.0) and p value for linearity 0.008. No significant association was observed 
in women. 
     Psychological distress was also associated with CRP levels representing high relative 
cardiovascular risk (hsCRP > 3.00 mg/l). After adjusting for gender, age, BMI, smoking, 
use of alcohol and leisure time physical activity, odds-ratios for hsCRP > 3.00 mg/l in the 
groups that had medium and high psychological distress were 1.32 (95% CI: 0.81 to 2.16) 
and 1.79 (95% CI: 1.05 to 3.04), respectively, compared with the low distress group (p for 
linearity 0.032), supporting a direct, physiological link between psychological distress and 
inflammation. Thus, inflammation (indicated by CRP) could be an important 
pathophysiological mechanism through which psychological factors are associated with 
cardiovascular disease.   
     In addition, subjects with high psychological distress at baseline were more than twice 
as likely to develop MetS than those with low psychological distress (OR 2.18, 95% CI 1.30 
to 3.64). Adjustments for 1) age, gender and other socio-demographic variables, 2) health 
behaviors (smoking, alcohol use and leisure time physical activity) and 3) CRP in the 
analysis diminished the odds of developing MetS in the distressed group (OR 1.87, 1.83 
and 1.81, respectively); however, the association remained statistically significant (p=0.025 
– 0.038). These prospective findings are evidence of a significant, independent association 
between psychological distress and the development of MetS. 
     Finally, high psychological distress was associated with increased all-cause mortality 
risk during an 11-year observation time. The 10-year survival for psychologically 
distressed subjects was 91% (95% CI: 85-94) and for non-distressed 97% (95% CI: 95-98), 
HR = 2.42 (95% CI: 1.30-4.52, p=0.005). When men and women were examined separately, a 
statistically significant gender difference was observed.  In men, the 10-year survival for 
distressed was 84% (95% CI: 73-91) and for non-distressed 96% (95% CI: 93-97), HR = 3.38 
(95% CI: 1.55-7.39, p=0.002). Among women, there was no significant association between 
high psychological distress and all-cause mortality. When GHQ-12 was used as a 
continuous variable, the hazard ratio (HR) increased by 16% for every GHQ-12 point (HR 
1.16, 95% CI: 1.08-1.25, p<0.001). The HR per GHQ-12 point decreased only slightly with 
additive adjustments with gender and age [1.16 (1.07-1.25)], BMI [1.16 (1.07-1.25)], 
socioeconomic status [1.14 (1.05-1.24)], and smoking and physical activity [1.13 (1.04-1.22)]. 
There results suggest a direct, independent association between psychological distress and 
premature mortality with a possible gender difference.  
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6.2 STUDY POPULATION, METHODS AND DESIGN 
The study population consisted of middle-aged (mean age 46 years) Caucasian subjects 
born in 1942, 1947, 1952, 1957 and 1962 in Pieksämäki, Finland. The entire age groups were 
recruited from the local comprehensive population records by three separate invitations. 
No exclusion criteria were applied. Altogether, 923 of 1294 subjects (71.3%) participated in 
a cross-sectional study from 1997-1998 at Pieksämäki health center. There is no data on the 
missing 28.7% who did not attend despite three invitations, but the missing subjects were 
evenly distributed to all age groups. It is unlikely that this will have a significant effect on 
the study results. 
     Because of the rather low mean age of the subjects, there were only few cases on 
cholesterol lowering medication [15 men (4%) and 6 women (1%)] or anti-diabetic 
medication [10 men (2%) and 4 women (1%)]. Anti-hypertensive medication was 
somewhat more common [44 men (11%) and 46 women (9%)]. It is unlikely that these 
figures will introduce a bias on the study results.  
     The distribution of GHQ-12 was very positively skewed with 55% of subjects scoring 0 
points. However, the distribution functions were equal in both genders. There were also 
no significant differences between genders in mean GHQ-12 scores or in individual GHQ-
12 items. This makes it unlikely that the observed gender differences in studies I and IV 
were due to different answering patterns or different distribution functions among men 
and women. In addition, the GHQ-12 loaded in only one factor in this study, supporting 
previous studies on unidimensional nature of the questionnaire (65).  
     One of the strengths of this study is its broad, population-based sampling from five age 
groups in a geographically defined area. However, the study group was genetically 
homogenous, which limits the possibility to generalize the results to a wider population. 
Some additional limitations of the present study warrant consideration. First, the 
identification of psychological distress was based on a self-reported scale (GHQ-12), not a 
diagnostic interview. Second, the data on baseline comorbidity was limited. The presence 
of pre-existing disease at baseline could contribute to both high distress and subsequent 
morbidity and mortality rates, and introduce a potential bias. Third, studies I and II were 
cross-sectional. Thus, the direction of causation of psychological distress with CVD risk 
and CRP levels cannot be evaluated. Study I also lacked the actual CVD mortality and 
morbidity data. Fourth, in the prospective studies III and IV, the information concerning 
e.g. psychological distress, health behaviors and level of inflammation was gathered only 
at baseline. We cannot evaluate the consistency of this information during the observation 
time, nor the chronicity of psychological distress measured by the GHQ-12. Likewise, the 
variables defining the metabolic syndrome in study III were measured only at baseline 
and at the end of follow-up. This introduced a potential bias that could not be controlled; 
some subjects may have developed MetS at some stage during follow-up but recovered 
and were again free of the syndrome at the end of follow-up period.    
6.3 GENDER-SPECIFIC ASSOCIATION OF PSYCHOLOGICAL DISTRESS 
WITH CARDIOVASCULAR RISK SCORES (STUDY I) 
The novel finding in this study was the gender-specific association of psychological 
distress with the CVD risk scores. Among men, significant psychological distress was 
associated with increased mean European and Framingham CVD risk scores. No such 
association was observed in women.  
46 
 
 
     Previous literature on psychological factors and CVD among women is rather limited. 
Denollet et al. (2008) (166) reported a significant association of CVD with anxiety and 
Rosengren et al. (2004) (167) with stress, locus of control and depression.  However, the 
existence of a possible gender difference in CVD risk, when measuring general 
psychological distress, has not been properly studied. Robinson et al. (2004) (6) reported 
that high levels of psychological distress (GHQ-12) almost doubled the risk of death for 
ischemic heart disease, but men and women were analyzed as one group. Some other 
studies linking GHQ with CVD mortality included only men as study subjects (163-165). 
Only two studies have reported results stratified by gender. Stansfeld et al. (2002) (162) 
reported also in women a significant association of psychological distress (GHQ-30) with 
self-reported coronary heart disease. Using the GHQ-12, Hamer et al. (2008) (7) reported 
similar effects of psychological distress on CVD both among men and women, but the 
statistical significance was not reported.  
     In this study, the risk scores among women were rather low and showed only little 
variance as compared to men. As a consequence, correlations as strong as those found 
among men may not be expected. However, it is unlikely, that this could fully explain the 
observed gender-specific association of GHQ-12 with CVD. The number of female 
participants in the sample was higher, which should provide enough statistical strength to 
detect a significant association also among women, if there was a one.   
      Why does the association between psychological distress and CVD risk appear to be 
more consistent in men than in women? There is an exponential increase in cardiac 
incidence in women around the age of 55-60 years (235,236). In the current study, subjects 
were between the ages of 35-55 years, making it possible that the association reported in 
men becomes significant later in women. Alternatively, women may cope better with 
psychological distress. Further research is needed to elucidate, whether psychological 
distress causes gender-specific changes in health behavior, e.g., smoking initiation or lack 
of physical activity, which could act as mediators between psychological distress and 
CVD. 
     The relationship between psychological distress and CVD risk is multi-factorial, as 
biological, environmental, social and behavioral pathways all play important roles. The 
relative contribution of different mediating variables has been studied to some extent 
(7,123,162). Considering biologic pathways, Everson-Rose et al. (2005) (3) suggested four 
main mechanisms through which psychological factors may cause CVD mortality in their 
review: 1) activation of the hypothalamic-pituitary-adrenal axis and the autonomic 
nervous system, 2) serotonergic dysfunction, 3) secretion of pro-inflammatory cytokines 
and 4) platelet activation. Further research is needed to determine the roles of different 
environmental, social, behavioral and biologic pathways in explaining the gender-specific 
association of psychological distress with CVD risk scores observed in the current study.  
     It can be concluded that psychological distress is strongly associated with 
cardiovascular risk scores in men and should be taken into account (e.g., by using the 
GHQ-12) when using CVD risk assessment tools. There seems to be a gender-specific 
association between psychological distress and CVD risk, because although women report 
higher mean levels of psychological distress, there is no significant association between 
high psychological distress and elevated CVD risk scores in women.  
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6.4 PSYCHOLOGICAL DISTRESS AND C-REACTIVE PROTEIN (STUDY II) 
In this cross-sectional study, high levels of psychological distress were associated with 
older age, low leisure time physical activity, elevated mean hsCRP level and higher 
prevalence of high relative cardiovascular risk (hsCRP > 3.00 mg/l).  There was no 
significant association between psychological distress and most traditional CVD risk 
factors (gender, BMI, waist circumference, smoking status, use of alcohol, blood pressure, 
serum cholesterol or fasting plasma glucose levels). The association between psychological 
distress and hsCRP levels representing high relative cardiovascular risk remained strong 
after adjusting for potential mediators (gender, age, BMI, smoking, use of alcohol and 
leisure time physical activity).  
     Previous studies have reported mixed results in the association of psychological factors 
with hsCRP concentration, see 2.2. In a recently published population-based study with 
over 6000 subjects by Elovainio et al. (2009) (115), higher level of depressive symptoms 
(measured by the BDI-21) was related to higher CRP levels in both men and women. In 
men, this relationship persisted after separate adjustment for other risk factors (i.e., age, 
education, BMI, health behaviours, serum cholesterol levels and blood pressure), but was 
no longer significant after adjustment for all the variables. In women, the relationship 
attenuated to the null after adjustment for obesity. The association of the GHQ-12 with 
elevated hsCRP concentration reported in this study is in accordance with an earlier 
epidemiological study by Hamer et al. (2008) (7), in which elevated hsCRP concentration 
was associated with high psychological distress (GHQ 4-12 points) after adjustment for 
age, gender, physical activity, smoking, use of alcohol, obesity and hypertension. Results 
by Hamer et al., together with the current study, indicate that at least general 
psychological distress is indeed associated with inflammation. 
     In the current study, after adjusting for potential mediators, increasing hsCRP levels 
were associated with elevated mean GHQ-12 score (Figure 5). On the other hand, 
increasing psychological distress was also associated with elevated hsCRP levels (Figure 6, 
Table 6). The direction of the association between psychological factors and inflammation 
remains controversial and cannot be evaluated in a cross-sectional setting. There are some 
prospective studies to tackle this problem. Gimeno et al. (2009) (122) reported that baseline 
hsCRP predicted depression at follow-up, while baseline symptoms of depression were 
not associated with hsCRP levels at follow-up. Nabi et al. (2008) (123) reported that 
psychological distress did not predict elevated hsCRP concentration at follow-up. In 
contrast, in a study by Fuligni et al. (2009) (124), greater frequency of daily interpersonal 
stress was associated with higher levels of hsCRP at follow-up among adolescents. More 
research is needed to clarify the direction of causality.  
     Psychological factors and systemic inflammation can interact through many 
mechanisms. Health behaviour could act as a mediator. Psychological distress has been 
reported to be associated with increased smoking, excess use of alcohol, sedentary lifestyle  
and obesity, which all have been associated with  elevated hsCRP concentration in 
previous studies, see 2.2.1.2 and 2.2.1.3. In the present study, levels of behavioural factors 
(smoking, use of alcohol) and mean BMI were similar in subjects with low and high 
psychological distress; only the level of physical activity differed between the groups. 
Moreover, the association of psychological distress with hsCRP levels persisted after 
adjustment for these factors, making it unlikely that health behaviours and obesity 
explained the association in question.  
     Psychological factors and systemic inflammation also interact through complex 
pathophysiological mechanisms, see 2.2.1.4. Psychosocial stress activates the 
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hypothalamic-pituitary-adrenocortical (HPA) axis and sympathetic nervous system, which 
releases various stress hormones (i.e., catecholamines, corticosteroids, growth hormone 
and glucagons). These, together with cytokines induced by stress, initiate the acute phase 
response. More prospective, population-based studies with repeated measurements of 
inflammation and markers of other proposed physiological pathways (e.g. HPA 
dysregulation) are needed to further clarify the mechanisms through which psychological 
distress and inflammation are related.  
      In conclusion, psychological distress was associated with elevated hsCRP levels 
representing high relative cardiovascular risk in this cross-sectional study.  The association 
remained robust after adjusting for health behaviours and pathophysiological factors, 
supporting a direct, physiological link between psychological distress and inflammation. 
There was no association between psychological distress and most traditional CVD risk 
factors (gender, BMI, waist circumference, smoking status, use of alcohol, blood pressure, 
serum cholesterol or fasting plasma glucose levels). These results support the hypothesis 
that C-reactive protein could be an important pathophysiological mechanism through 
which psychological factors are associated with cardiovascular disease.   
6.5 PSYCHOLOGICAL DISTRESS AND THE DEVELOPMENT OF THE 
METABOLIC SYNDROME (STUDY III) 
This prospective study shows that general psychological distress measured by the GHQ-
12 at baseline increases the risk of developing the metabolic syndrome during follow-up. 
This association remained robust after adjusting for age, gender, socio-demographic 
variables, baseline health behaviors and hsCRP level.  These prospective findings are 
evidence of a significant association between psychological distress and the development 
of MetS.  Because there was no significant difference between the distressed and non-
distressed subjects in the variables defining MetS (waist circumference, blood pressure, 
fasting plasma glucose, HDL cholesterol and triglycerides) at baseline, pre-existing 
physiological risk is unlikely to explain the observed association.   
     Our findings are consistent with results from previously published prospective studies 
on psychological factors and the occurrence of MetS, see  2.4.2. However, the findings 
from previous studies are confined to depressive symptoms or chronic stress. None of the 
studies found an association between symptoms of anxiety and risk of developing MetS. 
There are no previous prospective studies on psychological distress measured by the 
GHQ-12 and the occurrence of MetS. In stead of measuring depression or anxiety, the 
current study examined psychological distress because this construct may identify a larger 
group of individuals at risk of MetS and psychological distress may be a precipitant of 
clinical depression. 
     The association between depressive symptoms measured by the Beck depression 
inventory (BDI) and the development of MetS has been studied previously in the same 
middle-aged, population-based prospective sample used in this study (200). After 
adjusting for age, socio-economic status, health behaviors and use of medication, a 2.5-fold 
risk (95% CI 1.2 to 5.2) was reported for women with depressive symptoms (BDI ≥10) at 
baseline to have MetS at the end of follow-up, compared to non-depressive women.  
Among men, there was no risk difference. In the current study, the adjusted odds ratio for 
subjects with high psychological distress (GHQ 4-12) to have MetS at the end of follow-up 
was 1.83 (95% CI 1.05 to 3.21). The occurrence rate of MetS per 1000 person-years was 
similar in both genders [34 (95% CI 24 to 46) for men and 34 (95% CI 26 to 43) for women]. 
There was no interaction effect with gender in the current study. Based on the results of 
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these two studies, measuring general psychological distress with the GHQ-12 seems to 
have a greater prediction value for the development of MetS among men compared to 
measuring depressive symptoms with BDI, although GHQ-12 and BDI were highly 
correlated in the current study (Spearman’s rho 0.67). The exact reason for this result is 
unknown, but it is possible that GHQ-12 captures the affective experience of men in a way 
the BDI does not.  
     Several mechanisms may explain the association between psychological factors and 
MetS. In a model proposed by Goldbacher et al. (2007) (14), psychological factors may 
contribute to the pathogenesis of MetS via physiological and behavioral mediating 
pathways, while demographic characteristics, such as gender, age and socio-economic 
status, influence the association. Psychological distress has been associated with health-
damaging behaviors, such as excessive use of alcohol, smoking, sedentary lifestyle and 
unhealthy diet, which could increase the risk of developing MetS (see 2.4.3.2). The current 
study is unique, because it examined the role of different behavioral patterns as well as 
demographic characteristics in a prospective, population-based setting. Subjects with high 
psychological distress were older, predominantly female, less physically active and lived 
more often alone at baseline. However, the association between psychological distress and 
the occurrence of MetS remained strong in the multivariate relative risk analysis after 
adjusting for age, gender and socio-economic status. The additional inclusion of health 
behaviors (smoking status, use of alcohol and leisure time physical activity) in the analysis 
had a very minor effect on the relationship between psychological distress and the odds of 
developing MetS. In this fully adjusted model with demographic and behavioral factors, 
only age and smoking status had a significant effect on the odds of developing MetS in 
addition to psychological distress. This suggests that although health behaviors and 
demographic characteristics are associated with psychological distress, they do not alone 
explain the observed causal relationship between psychological distress and the 
development of MetS. Unfortunately, because there were no data on dietary habits of the 
subjects, the possible role of unhealthy diet could not be evaluated.  
     Inflammation is a recently purported physiological mechanism linking psychological 
distress to the development of MetS, see 2.4.4. Capuron et al. (2008) (192) reported in a 
cross-sectional study setting that after adjusting for age, education and smoking status, 
MetS was significantly associated with depressive symptoms. A further adjustment for 
CRP decreased the coefficient for MetS somewhat, but the association remained 
statistically significant. The current study offered the opportunity to examine the influence 
of CRP levels in the relationship between psychological distress and the occurrence of 
MetS in a prospective manner. When baseline hsCRP levels were included in the 
multivariate model assessing the risk of developing MetS, this had very little effect on the 
odds ratios of psychological distress, demographic factors or health behaviors. In fact, 
baseline levels of hsCRP were not significantly associated with risk of development of 
MetS in this fully adjusted model. More prospective, population-based studies with 
measurements of inflammation and markers of other proposed physiological pathways 
(e.g. HPA dysregulation) as well as information on basic demographic and behavioral 
factors are needed to evaluate the exact roles of different pathways in influencing the 
association between psychological factors and the development of MetS.  
     There is some debate about whether the risk imparted by MetS as a single construct is 
higher than the risk imparted by the individual component factors themselves, and 
whether certain components are more important than others (237,238). In the study by 
Goldbacher et al. (2009) (203), depression was significantly associated with increasing 
odds for MetS as a single construct, but the association with individual components of 
MetS did not reach statistical significance. In the current study, high psychological distress 
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increased significantly the risk of meeting the NCEP criteria in low HDL cholesterol and in 
waist circumference. The associations with elevated blood pressure, fasting plasma 
glucose and triglycerides were not statistically significant. Thus, these results suggest that 
low HDL cholesterol and abdominal obesity might be the strongest individual 
components of MetS in the association with psychological distress.  
     In conclusion, psychological distress may be an important predisposing factor for the 
development of MetS, even after adjusting for age, gender, socio-economic status, health 
behaviors and hsCRP levels.  
6.6 PSYCHOLOGICAL DISTRESS AND ALL-CAUSE MORTALITY (STUDY 
IV) 
This is the first study in the Scandinavian population to show that psychological distress 
measured by the GHQ-12 is associated with increased all-cause mortality.  Our findings 
are consistent with results from previously published studies in British population 
(6,7,17,18). However, this association seems to be mainly due the excess mortality among 
distressed men. Although women reported higher mean levels of psychological distress, 
no significant association with mortality was observed. It is possible that the association in 
women is weaker, and could not be detected because of lack in statistical power due less 
death events among women. More large scale studies are needed to fully elucidate the 
possible gender difference. Unfortunately, the relative small number of death events made 
it impossible to study the association between psychological distress and mortality in a 
cause specific manner.  
     There are many possible mechanisms by which psychological distress may lead to 
premature mortality. In this study, the issue of confounding was considered in relation to 
BMI, socioeconomic status and health behaviours. Psychological distress has been 
associated with obesity, see 2.1.7. High education and marriage has been shown to 
decrease both the mortality risk and the level of psychological distress (17), see also 2.1.5. 
Behavioural changes, such as increased smoking and reduced leisure time physical 
activity, may occur as coping response to psychological distress (see 2.1.6), which could 
increase the risk of premature mortality.  In the current study, the association between 
psychological distress and mortality risk was attenuated only slightly by adjusting for 
these variables and remained significant. This makes it unlikely that the observed 
association between psychological distress and mortality was explained by differences in 
socioeconomic status or health behaviours. Unfortunately, no statistically robust gender 
stratified adjustments with socioeconomic and behavioural variables could be done due to 
the small number of death events of this study.   
     The possible pathophysiological mechanisms linking psychological distress and 
premature mortality include e.g. altered functioning of the hypothalamic pituitary 
adrenocortical (HPA) axis and sympathetic nervous system, which can trigger 
pathophysiological mechanisms that include inflammation, hemostasis, and altered 
metabolic and cardiac autonomic control (175). Psychological distress has been associated 
with elevated CRP concentration and, on the other hand, high CRP levels have been 
associated with all-cause mortality (see 2.5.1). In the current study, age and gender 
adjusted CRP was not significantly associated with all-cause mortality. Thus, the results 
do not support the role of CRP as a direct, causal link between psychological distress and 
mortality. Unfortunately, the relative contribution of other physiological factors (e.g., 
cortisol) could not be examined in the current study.  
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     A specific limitation of this study is the inability to control for the presence of pre-
existing disease at baseline which might contribute to both high distress and subsequent 
mortality rates. This has also not been controlled in any previous studies using the GHQ-
12. When using the longer, 30-item version of the GHQ, a positive relationship between 
high GHQ scores and mortality was observed both for people with and without limiting 
disease (231).   
     It can be concluded that psychological distress is associated with all-cause mortality 
risk during an 11-year observation time, mainly due the excess mortality among distressed 
men. This association was attenuated only slightly by adjusting for age, BMI,  education, 
marital status and health behaviours, speaking of direct, independent association between 
psychological distress and premature mortality. 
6.7 IMPLICATIONS FOR CLINICAL PRACTICE AND RESEARCH  
Although GHQ-12 has wide acceptance as a screening instrument, there is debate about 
the efficacy of screening and case detection for psychological factors in clinical practice. 
When compared to normal circumstances without screening, GHQ-12 used in an ordinary 
general practice environment was able to detect one additional patient with a real 
diagnostic psychological problem for every five patients screened, when used with 
infrequently seen patients, but screening of well-known patients provided less additional 
cases (239). This implicates that routine screening for psychological distress should be 
carefully targeted.   
     According to this study, psychological distress is strongly associated with 
cardiovascular risk scores in men. These results have some important implications for 
clinical practice. First, psychological distress should be taken into account (e.g., by using 
the GHQ-12) when using CVD risk assessment tools in men. Second, new CVD risk 
evaluation tools for clinical practice, which would also assess psychological factors, may 
be worth developing in the future. 
     This study also confirms that psychological distress is independently associated with 
elevated hsCRP levels representing high relative cardiovascular risk (CRP > 3 mg/l). Thus, 
inflammation (indicated by CRP) could be an important pathophysiological mechanism 
through which psychological factors are associated with cardiovascular disease. When 
using the CVD risk assessment tools in patients with high psychological distress, 
measuring the high-sensitivity CRP concentration may offer additional risk prediction 
power.  
     In addition, the current results suggest that psychological distress may be important 
predisposing factor for the development of metabolic syndrome, even after adjusting for 
age, gender, socio-economic status, health behaviours and hsCRP levels. Thus, it is 
reasonably to assume that effective treatment of psychological distress could also help to 
reduce the incidence of MetS. Results also highlight the importance of assessing the risk 
for MetS when treating patients with psychological distress.  
     Finally, this study has shown that psychological distress is independently associated 
with all-cause mortality risk, mainly due the excess mortality among distressed men. 
Although health care professionals possibilities to influence the patient’s psychological 
distress status are limited, it is important to be aware of the excess mortality risk of the 
distressed patients. Also smoking has a significant, independent role in this association, 
and should therefore be targeted by clinicians. 
     The results of this study have also some implication for future research. First, more 
prospective, population-based studied are needed with multiple measurement of 
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psychological distress, health behaviours and clinical/biochemical factors during follow-
up in order to evaluate the exact roles of different environmental, social, behavioural and 
physiological pathways in the association of psychological distress with all-cause 
mortality, CVD mortality and morbidity and the development of MetS. Second, a more 
comprehensive analysis of health behaviours (including information on e.g. dietary habits 
and sleep) is needed in future research. Third, a prospective study setting with multiple 
measurements (including levels of cortisol and other inflammatory markers) during 
follow-up is also needed to clarify the direction of causality and the pathophysiological 
mechanism between psychological distress and CRP levels.  
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7 Summary 
This study was done to evaluate the association of general psychological distress with 
cardiovascular risk, metabolic syndrome and all-cause mortality in a community-based 
population sample. It also evaluated the role of C-reactive protein in these associations. 
Five different whole age groups, aged 36 to 56 years, were recruited from the local 
comprehensive population records by three separate invitations, and 923 of 1294 subjects 
(71.3%) participated in a cross-sectional study from 1997-1998 at Pieksämäki health center. 
In 2004-2005, 688 of the original 923 subjects (74.5%) took part in the 7-year follow-up visit. 
Mortality data until 31 December 2009 were drawn from the national mortality register 
(Statistics Finland). Psychological distress was measured in 1997-1998 using the 12-item 
General Health Questionnaire (GHQ-12).  
     The study showed that men with high psychological distress had 28-44% higher 
cardiovascular risk scores compared to men with low distress. There seems to be a gender-
specific association between psychological distress and cardiovascular risk, because 
although women report higher mean levels of psychological distress, there was no 
significant association between high psychological distress and elevated cardiovascular 
risk scores in women.  
     In order to examine the role of C-reactive protein (CRP) in this association, the 
relationship between psychological distress and elevated CRP levels representing high 
relative cardiovascular risk was studied next. As a summary, subjects with high 
psychological distress had a 1.79-fold risk for high CRP level compared to subjects with no 
distress, although age, gender, body-mass index and health behaviours were accounted 
for. However, there was no association between psychological distress and most 
traditional cardiovascular risk factors, supporting the hypothesis that inflammation 
(indicated by CRP) could be an important pathophysiological mechanism through which 
psychological factors are associated with cardiovascular disease.   
     The metabolic syndrome is a cluster of factors that increases the risk of cardiovascular 
diseases and all-cause mortality. This study showed that high psychological distress is 
associated with a two-fold relative risk for the development of metabolic syndrome, even 
after adjusting for age, gender, socio-economic status and health behaviours. There was no 
support for an independent, mediating role of CRP in this association.   
     High psychological distress was also associated with a 2.4-fold all-cause mortality risk 
during an 11-year observation time, mainly due the excess mortality among distressed 
men. This association was attenuated only slightly, when body-mass index, education, 
marital status and health behaviours where accounted for, supporting a direct, 
independent association between psychological distress and premature mortality. CRP 
concentration was not associated with mortality.  
     In conclusion, high psychological distress measured by the 12-item General Health 
Questionnaire was associated with elevated C-reactive protein concentration, increased 
risk for developing the metabolic syndrome and premature mortality. In addition, men 
with high psychological distress had significantly elevated cardiovascular risk scores.  
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The association of clinical depres-
sion and anxiety with increased 
mortality and morbidity is well 
documented, but less is known about 
the effects of general psychological 
distress. The results of this study 
support a direct, independent as-
sociation of psychological distress 
with development of the metabolic 
syndrome and premature mortality. 
In addition, psychological distress is 
associated with inflammation among 
both genders and significantly el-
evated cardiovascular risk scores 
among men.
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